SECTION ID="" TYPE="doc_segment" TITLE="" START="0" END="7"
SECTION ID="" TYPE="doc_segment" TITLE="" START="0" END="147"
0 <ENAMEX type="TERM" id="NYU_TERM_43" string="HDAC1" frequency="8" lemma="HISTONE DEACETYLASE 1" lemma_frequency="8" term_pattern_type="chunk-based:['NOUN_OOV']">HDAC1</ENAMEX>. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="7" END="20"
7 <ENAMEX type="TERM" id="NYU_TERM_138" string="Introduction" frequency="2" lemma="INTRODUCTION" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN']">Introduction </ENAMEX>
SECTION ID="" TYPE="doc_segment" TITLE="" START="20" END="1494"
20 <ENAMEX type="TERM" id="NYU_TERM_167" string="Preimplantation embryo development" frequency="2" lemma="PREIMPLANTATION EMBRYO DEVELOPMENT" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">Preimplantation embryo development </ENAMEX>includes <ENAMEX type="TERM" id="NYU_TERM_389" string="fertilization" frequency="2" lemma="FERTILIZATION" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN']">fertilization</ENAMEX>, cell cleavage, <ENAMEX type="TERM" id="NYU_TERM_484" string="morula" frequency="5" lemma="MORULA" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV']">morula </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_262" string="blastocyst formation" frequency="3" lemma="BLASTOCYST FORMATION" lemma_frequency="3" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst formation</ENAMEX>. 
127 The formation of a healthy <ENAMEX type="TERM" id="NYU_TERM_259" string="blastocyst" frequency="3" lemma="BLASTOCYST" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">blastocyst </ENAMEX>is critical for subsequent <ENAMEX type="TERM" id="NYU_TERM_419" string="implantation" frequency="1" lemma="IMPLANTATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">implantation</ENAMEX>, pregnancy and <ENAMEX type="TERM" id="NYU_TERM_391" string="fetal development" frequency="1" lemma="FETAL DEVELOPMENT" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">fetal development </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_1">Watson & Barcroft, 2001</ENAMEX>). 
265 The <ENAMEX type="TERM" id="NYU_TERM_551" string="preimplantation embryo" frequency="2" lemma="PREIMPLANTATION EMBRYO" lemma_frequency="4" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation embryo </ENAMEX>exhibits an <ENAMEX type="TERM" id="NYU_TERM_255" string="autonomous development capability" frequency="1" lemma="AUTONOMOUS DEVELOPMENT CAPABILITY" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">autonomous development capability </ENAMEX>influenced by various factors within the maternal and <ENAMEX type="TERM" id="NYU_TERM_365" string="embryonic environment" frequency="1" lemma="EMBRYONIC ENVIRONMENT" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">embryonic environment </ENAMEX><ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_2">(Schultz, 2005). Similarly</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_423" string="in vitro culture conditions" frequency="1" lemma="IN VITRO CULTURE CONDITION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'AMBIG_PLURAL']">in vitro culture conditions </ENAMEX>also exert crucial effects on <ENAMEX type="TERM" id="NYU_TERM_343" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo </ENAMEX><ENAMEX type="TERM" id="NYU_TERM_324" string="developmental potential" frequency="2" lemma="DEVELOPMENTAL POTENTIAL" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental potential </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_3">Niemann & Wrenzycki, 2000</ENAMEX>; <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_4">Schultz & Williams, 2002</ENAMEX>; <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_5">Ecker et al., 2004</ENAMEX>). 
606 In <ENAMEX type="TERM" id="NYU_TERM_296" string="clinical assisted reproductive technology" frequency="1" lemma="CLINICAL ASSISTED REPRODUCTIVE TECHNOLOGY" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">clinical assisted reproductive technology</ENAMEX>, embryos are selected for transfer based mainly on <ENAMEX type="TERM" id="NYU_TERM_482" string="morphological criteria" frequency="1" lemma="MORPHOLOGICAL CRITERION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">morphological criteria</ENAMEX>, which to some extent reflect their <ENAMEX type="TERM" id="NYU_TERM_325" string="developmental potential" frequency="2" lemma="DEVELOPMENTAL POTENTIAL" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental potential</ENAMEX>. 
786 In most cases, <ENAMEX type="TERM" id="NYU_TERM_308" string="day-2" frequency="1" lemma="DAY-2" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">day-2 </ENAMEX>or <ENAMEX type="TERM" id="NYU_TERM_309" string="day-3 cleavage-stage embryos" frequency="1" lemma="DAY-3 CLEAVAGE-STAGE EMBRYO" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN', 'PLURAL']">day-3 cleavage-stage embryos </ENAMEX>are usually transferred. 
864 Human <ENAMEX type="TERM" id="NYU_TERM_367" string="embryonic genome activation" frequency="1" lemma="EMBRYONIC GENOME ACTIVATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV', 'NOUN']">embryonic genome activation </ENAMEX>(EGA) occurs from the 4 8-cell stage (<ENAMEX type="TERM" id="NYU_TERM_9" string="Braude" frequency="1" lemma="BRAUDE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Braude </ENAMEX>et al., 1988), which makes <ENAMEX type="TERM" id="NYU_TERM_354" string="embryo selection" frequency="1" lemma="EMBRYO SELECTION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">embryo selection </ENAMEX>at earlier <ENAMEX type="TERM" id="NYU_TERM_330" string="developmental stages" frequency="3" lemma="DEVELOPMENTAL STAGE" lemma_frequency="4" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">developmental stages </ENAMEX>less reliable. 
1034 In reality, prolonged culture is not always utilized as a <ENAMEX type="TERM" id="NYU_TERM_585" string="selection tool" frequency="1" lemma="SELECTION TOOL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">selection tool </ENAMEX>because <ENAMEX type="TERM" id="NYU_TERM_246" string="aneuploidies" frequency="1" lemma="ANEUPLOIDY" lemma_frequency="1" term_pattern_type="chunk-based:['PLURAL']">aneuploidies </ENAMEX>or aberrant <ENAMEX type="TERM" id="NYU_TERM_395" string="gene expression" frequency="3" lemma="GENE EXPRESSION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">gene expression </ENAMEX>prevent development to the <ENAMEX type="TERM" id="NYU_TERM_266" string="blastocyst stage" frequency="7" lemma="BLASTOCYST STAGE" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst stage </ENAMEX>in a large proportion of embryos (<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_6">Gardner et al., 1998</ENAMEX>; 
1256 <ENAMEX type="TERM" id="NYU_TERM_25" string="Dal Canto" frequency="1" lemma="DAL CANTO" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'AMBIG_NOUN']">Dal Canto </ENAMEX>et al., 2012). 
1281 Hence, it is imperative to characterize the mechanisms controlling <ENAMEX type="TERM" id="NYU_TERM_539" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development</ENAMEX>, to further <ENAMEX type="CITATION" id="NYU_RELATION_50" nyu_id="E50" cite_class="article_self_cite">our </ENAMEX>understanding of basic <ENAMEX type="TERM" id="NYU_TERM_574" string="reproductive biology" frequency="1" lemma="REPRODUCTIVE BIOLOGY" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">reproductive biology</ENAMEX>, as well as advance <ENAMEX type="TERM" id="NYU_TERM_537" string="practical applications" frequency="1" lemma="PRACTICAL APPLICATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">practical applications </ENAMEX>in the clinic. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="1494" END="2910"
1494 <ENAMEX type="TERM" id="NYU_TERM_169" string="Preimplantation embryonic development" frequency="1" lemma="PREIMPLANTATION EMBRYONIC DEVELOPMENT" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">Preimplantation embryonic development </ENAMEX>is regulated both genetically and epigenetically. 
1582 The global <ENAMEX type="TERM" id="NYU_TERM_398" string="gene expression profile" frequency="1" lemma="GENE EXPRESSION PROFILE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN', 'NOUN']">gene expression profile </ENAMEX>is dynamic and displays <ENAMEX type="TERM" id="NYU_TERM_594" string="stage-specific characteristics" frequency="1" lemma="STAGE-SPECIFIC CHARACTERISTIC" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'PLURAL']">stage-specific characteristics </ENAMEX>at different <ENAMEX type="TERM" id="NYU_TERM_331" string="developmental stages" frequency="3" lemma="DEVELOPMENTAL STAGE" lemma_frequency="4" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">developmental stages </ENAMEX>of the <ENAMEX type="TERM" id="NYU_TERM_552" string="preimplantation embryo" frequency="2" lemma="PREIMPLANTATION EMBRYO" lemma_frequency="4" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation embryo</ENAMEX>. 
1737 For example, <ENAMEX type="TERM" id="NYU_TERM_160" string="Oct4" frequency="1" lemma="OCT4" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Oct4</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_154" string="Nanog" frequency="1" lemma="NANOG" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Nanog</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_33" string="Gata3" frequency="1" lemma="GATA3" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Gata3 </ENAMEX>and Bmp8b are activated between the 4 8-cell <ENAMEX type="TERM" id="NYU_TERM_368" string="embryonic stage" frequency="1" lemma="EMBRYONIC STAGE" lemma_frequency="3" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">embryonic stage </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_55" string="Hamatani" frequency="2" lemma="HAMATANI" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Hamatani </ENAMEX>et al., 2004). 
1855 These genes are <ENAMEX type="TERM" id="NYU_TERM_444" string="key regulators" frequency="1" lemma="KEY REGULATOR" lemma_frequency="1" term_pattern_type="chunk-based:['AMBIG_NOUN', 'PLURAL']">key regulators </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_334" string="differentiation" frequency="1" lemma="DIFFERENTIATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">differentiation </ENAMEX>into the inner cell mass (ICM) and <ENAMEX type="TERM" id="NYU_TERM_614" string="trophectoderm" frequency="1" lemma="TROPHECTODERM" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">trophectoderm </ENAMEX>(TE), which is the very first cell lineage specification in mouse <ENAMEX type="TERM" id="NYU_TERM_356" string="embryonic development" frequency="6" lemma="EMBRYONIC DEVELOPMENT" lemma_frequency="6" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">embryonic development </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_7">Yamanaka et al., 2006</ENAMEX>). 
2067 Many studies have suggested that <ENAMEX type="TERM" id="NYU_TERM_22" string="DNA methylation" frequency="1" lemma="DNA METHYLATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV']">DNA methylation </ENAMEX>and the regulation of <ENAMEX type="TERM" id="NYU_TERM_413" string="histone modifications" frequency="1" lemma="HISTONE MODIFICATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">histone modifications </ENAMEX>have profound effects on <ENAMEX type="TERM" id="NYU_TERM_553" string="preimplantation embryonic development" frequency="7" lemma="PREIMPLANTATION EMBRYONIC DEVELOPMENT" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">preimplantation embryonic development </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_8">Monk et al., 1987</ENAMEX>; 
2243 <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_9">Santos et al., 2005</ENAMEX>; 
2264 <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_10">Yeo et al., 2005</ENAMEX>; 
2282 <ENAMEX type="TERM" id="NYU_TERM_220" string="Torres-Padilla" frequency="1" lemma="TORRES-PADILLA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Torres-Padilla </ENAMEX>et al., 2006). 
2312 Two major <ENAMEX type="TERM" id="NYU_TERM_411" string="histone deacetylase" frequency="1" lemma="HISTONE DEACETYLASE" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">histone deacetylase </ENAMEX>(HDAC) complexes (<ENAMEX type="TERM" id="NYU_TERM_159" string="NuRD" frequency="1" lemma="NURD" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">NuRD </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_196" string="SIN3" frequency="1" lemma="SIN3" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">SIN3</ENAMEX>) have specific functions in <ENAMEX type="TERM" id="NYU_TERM_357" string="embryonic development" frequency="6" lemma="EMBRYONIC DEVELOPMENT" lemma_frequency="6" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">embryonic development </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_4" string="Ahringer" frequency="1" lemma="AHRINGER" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Ahringer</ENAMEX>, 2000). 
2442 <ENAMEX type="TERM" id="NYU_TERM_45" string="HDAC1" frequency="8" lemma="HISTONE DEACETYLASE 1" lemma_frequency="8" term_pattern_type="chunk-based:['NOUN_OOV']">HDAC1 </ENAMEX>is a major <ENAMEX type="TERM" id="NYU_TERM_310" string="deacetylase" frequency="1" lemma="DEACETYLASE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">deacetylase </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_560" string="preimplantation embryos" frequency="2" lemma="PREIMPLANTATION EMBRYO" lemma_frequency="4" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">preimplantation embryos </ENAMEX>and its expression negatively regulates the <ENAMEX type="TERM" id="NYU_TERM_244" string="acetylation state" frequency="1" lemma="ACETYLATION STATE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">acetylation state </ENAMEX>of histone <ENAMEX type="TERM" id="NYU_TERM_37" string="H4K5" frequency="1" lemma="H4K5" lemma_frequency="1" head_term="H4K5" head_lemma="H4K5" term_pattern_type="chemical">H4K5 </ENAMEX>during <ENAMEX type="TERM" id="NYU_TERM_554" string="preimplantation embryonic development" frequency="7" lemma="PREIMPLANTATION EMBRYONIC DEVELOPMENT" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">preimplantation embryonic development </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_11">Ma & Schultz, 2008</ENAMEX>). 
2643 Although knowledge of the mechanisms of <ENAMEX type="TERM" id="NYU_TERM_540" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development </ENAMEX>has increased gradually over the past decade, the <ENAMEX type="TERM" id="NYU_TERM_447" string="key transcription factors" frequency="1" lemma="KEY TRANSCRIPTION FACTOR" lemma_frequency="1" term_pattern_type="chunk-based:['AMBIG_NOUN', 'NOUN', 'AMBIG_PLURAL']">key transcription factors </ENAMEX>that are essential for <ENAMEX type="TERM" id="NYU_TERM_264" string="blastocyst formation" frequency="3" lemma="BLASTOCYST FORMATION" lemma_frequency="3" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst formation </ENAMEX>and how they interact with <ENAMEX type="TERM" id="NYU_TERM_376" string="epigenetic regulators" frequency="1" lemma="EPIGENETIC REGULATOR" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">epigenetic regulators </ENAMEX>have yet to be characterized. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="2910" END="3823"
2910 <ENAMEX type="TERM" id="NYU_TERM_65" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>participates in <ENAMEX type="TERM" id="NYU_TERM_336" string="diverse cellular processes" frequency="1" lemma="DIVERSE CELLULAR PROCESS" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'AMBIG_PLURAL']">diverse cellular processes </ENAMEX><ENAMEX type="TERM" id="NYU_TERM_440" string="involving tumor suppression" frequency="1" lemma="INVOLVING TUMOR SUPPRESSION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN', 'NOUN']">involving tumor suppression</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_23" string="DNA repair" frequency="2" lemma="DNA REPAIR" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">DNA repair</ENAMEX>, cell cycle regulation, and <ENAMEX type="TERM" id="NYU_TERM_284" string="cellular senescence" frequency="1" lemma="CELLULAR SENESCENCE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">cellular senescence</ENAMEX>, all of which are functionally linked to the <ENAMEX type="TERM" id="NYU_TERM_528" string="p53 tumor suppressor protein" frequency="1" lemma="P53 TUMOR SUPPRESSOR PROTEIN" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN', 'NOUN', 'NOUN']">p53 tumor suppressor protein </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_236" string="Unoki" frequency="2" lemma="UNOKI" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Unoki </ENAMEX>et al., 2008; 
3141 <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_12">Zhang et al., 2008</ENAMEX>; Larrieu et al., 2009). 
3184 Additionally, <ENAMEX type="TERM" id="NYU_TERM_66" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>has <ENAMEX type="TERM" id="NYU_TERM_257" string="biological functions" frequency="1" lemma="BIOLOGICAL FUNCTION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">biological functions </ENAMEX>that are independent of the <ENAMEX type="TERM" id="NYU_TERM_527" string="p53 pathway" frequency="1" lemma="P53 PATHWAY" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">p53 pathway</ENAMEX>. 
3269 As a basic <ENAMEX type="TERM" id="NYU_TERM_599" string="subunit" frequency="2" lemma="SUBUNIT" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">subunit </ENAMEX>of the <ENAMEX type="TERM" id="NYU_TERM_412" string="histone deacetylase Sin3 complex" frequency="1" lemma="HISTONE DEACETYLASE SIN3 COMPLEX" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV', 'NOUN_OOV', 'NOUN']">histone deacetylase Sin3 complex</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_67" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>mediates the binding of the <ENAMEX type="TERM" id="NYU_TERM_208" string="Sin3 complex" frequency="2" lemma="SIN3 COMPLEX" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">Sin3 complex </ENAMEX>to some promoters where di-/tri-methylated <ENAMEX type="TERM" id="NYU_TERM_36" string="H3K4" frequency="1" lemma="H3K4" lemma_frequency="1" head_term="H3K4" head_lemma="H3K4" term_pattern_type="chemical">H3K4 </ENAMEX>regulates <ENAMEX type="TERM" id="NYU_TERM_400" string="gene repression" frequency="3" lemma="GENE REPRESSION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">gene repression </ENAMEX>(Smith et al., 2010). 
3471 <ENAMEX type="TERM" id="NYU_TERM_68" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>can also play a role in <ENAMEX type="TERM" id="NYU_TERM_473" string="modulating histone methyltransferase" frequency="1" lemma="MODULATING HISTONE METHYLTRANSFERASE" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN_OOV', 'NOUN_OOV']">modulating histone methyltransferase </ENAMEX>(HMT) activity associated with silencing function, which involves a <ENAMEX type="TERM" id="NYU_TERM_505" string="non-HDAC class I" frequency="1" lemma="NON-HDAC CLASS I" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN', 'ROMAN_NUMBER']">non-HDAC class I </ENAMEX>or II pathway (Goeman et al., 2008). 
3659 As <ENAMEX type="TERM" id="NYU_TERM_69" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>modulates both <ENAMEX type="TERM" id="NYU_TERM_396" string="gene expression" frequency="3" lemma="GENE EXPRESSION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">gene expression </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_289" string="chromatin modification" frequency="1" lemma="CHROMATIN MODIFICATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">chromatin modification</ENAMEX>, <ENAMEX type="CITATION" id="NYU_RELATION_51" nyu_id="E51" cite_class="article_self_cite">this study </ENAMEX>attempted to examine the role of <ENAMEX type="TERM" id="NYU_TERM_70" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>in mouse <ENAMEX type="TERM" id="NYU_TERM_555" string="preimplantation embryonic development" frequency="7" lemma="PREIMPLANTATION EMBRYONIC DEVELOPMENT" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">preimplantation embryonic development</ENAMEX>. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="3823" END="3845"
3823 Materials and methods 
SECTION ID="" TYPE="doc_segment" TITLE="" START="3845" END="3964"
3845 All chemicals and culture media were purchased from <ENAMEX type="TERM" id="NYU_TERM_202" string="Sigma-Aldrich" frequency="2" lemma="SIGMA-ALDRICH" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Sigma-Aldrich </ENAMEX>Inc. 
3916 (<ENAMEX type="TERM" id="NYU_TERM_211" string="St" frequency="2" lemma="ST" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">St</ENAMEX>. Louis, MO, <ENAMEX type="TERM" id="NYU_TERM_230" string="USA" frequency="6" lemma="USA" lemma_frequency="6" term_pattern_type="chunk-based:['NOUN_OOV']">USA</ENAMEX>), unless stated otherwise. 
SECTION ID="" TYPE="doc_segment" TITLE="Embryo collection and culture" START="3964" END="4949"
3964 <ENAMEX type="TERM" id="NYU_TERM_28" string="Embryo collection" frequency="1" lemma="EMBRYO COLLECTION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">Embryo collection </ENAMEX>and culture The <ENAMEX type="TERM" id="NYU_TERM_61" string="ICR mice" frequency="3" lemma="ICR MOUSE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ICR mice </ENAMEX>were <ENAMEX type="TERM" id="NYU_TERM_388" string="fed ad" frequency="1" lemma="FED AD" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">fed ad </ENAMEX>libitum with a standard diet and were housed in a room with controlled temperature and lighting (20 22 C, 12 h/12 <ENAMEX type="TERM" id="NYU_TERM_407" string="h light/dark cycle" frequency="1" lemma="H LIGHT/DARK CYCLE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV', 'NOUN']">h light/dark cycle</ENAMEX>), in accordance with the <ENAMEX type="TERM" id="NYU_TERM_137" string="Institutional Animal Care" frequency="1" lemma="INSTITUTIONAL ANIMAL CARE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'AMBIG_NOUN']">Institutional Animal Care </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_238" string="Use Committee" frequency="1" lemma="USE COMMITTEE" lemma_frequency="1" term_pattern_type="chunk-based:['AMBIG_NOUN', 'NOUN']">Use Committee </ENAMEX>(IACUC) guidelines of <ENAMEX type="ORGANIZATION" id="NYU_ID_153" string="Nanjing Medical University">Nanjing Medical University</ENAMEX>. 
4272 For the collection of <ENAMEX type="TERM" id="NYU_TERM_620" string="zygotes" frequency="6" lemma="ZYGOTE" lemma_frequency="8" term_pattern_type="chunk-based:['PLURAL']">zygotes</ENAMEX>, 8-week-old female <ENAMEX type="TERM" id="NYU_TERM_62" string="ICR mice" frequency="3" lemma="ICR MOUSE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ICR mice </ENAMEX>were injected with human <ENAMEX type="TERM" id="NYU_TERM_287" string="chorionic gonadotropin" frequency="2" lemma="CHORIONIC GONADOTROPIN" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">chorionic gonadotropin </ENAMEX>(HCG) and mated with male <ENAMEX type="TERM" id="NYU_TERM_63" string="ICR mice" frequency="3" lemma="ICR MOUSE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ICR mice </ENAMEX>shortly after <ENAMEX type="TERM" id="NYU_TERM_436" string="injection" frequency="2" lemma="INJECTION" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN']">injection</ENAMEX>. 
4438 After 21 h, <ENAMEX type="TERM" id="NYU_TERM_621" string="zygotes" frequency="6" lemma="ZYGOTE" lemma_frequency="8" term_pattern_type="chunk-based:['PLURAL']">zygotes </ENAMEX>were collected from the oviducts of the mated female mice and transferred into 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-buffered Chatot, <ENAMEX type="TERM" id="NYU_TERM_241" string="Ziomet" frequency="1" lemma="ZIOMET" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Ziomet </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_7" string="Bavister" frequency="1" lemma="BAVISTER" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Bavister </ENAMEX>(CZB) medium. 
4647 Cumulus cells were dispersed by treatment with 1 <ENAMEX type="TERM" id="NYU_TERM_461" string="mg/ml hyaluronidase" frequency="1" lemma="MG/ML HYALURONIDASE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV']">mg/ml hyaluronidase </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_53" string="HEPES-CZB" frequency="1" lemma="HEPES-CZB" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">HEPES-CZB</ENAMEX>. 
4730 <ENAMEX type="TERM" id="NYU_TERM_20" string="Cumulus-free zygotes" frequency="1" lemma="CUMULUS-FREE ZYGOTE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'PLURAL']">Cumulus-free zygotes </ENAMEX>were washed with <ENAMEX type="TERM" id="NYU_TERM_54" string="HEPES-CZB medium" frequency="1" lemma="HEPES-CZB MEDIUM" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">HEPES-CZB medium </ENAMEX>and then cultured in <ENAMEX type="TERM" id="NYU_TERM_13" string="CZB medium" frequency="2" lemma="CZB MEDIUM" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">CZB medium </ENAMEX>until they developed to later <ENAMEX type="TERM" id="NYU_TERM_293" string="cleavage-stage embryos" frequency="2" lemma="CLEAVAGE-STAGE EMBRYO" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'PLURAL']">cleavage-stage embryos</ENAMEX>. 
4871 All cultures were carried out within a humidified 5% <ENAMEX type="TERM" id="NYU_TERM_12" string="CO2" frequency="1" lemma="CO2" lemma_frequency="1" head_term="CO2" head_lemma="CO2" term_pattern_type="chemical">CO2 </ENAMEX>incubator at 37 C. 
SECTION ID="" TYPE="doc_segment" TITLE="Immunofluorescence and confocal microscopy" START="4949" END="5937"
4949 <ENAMEX type="TERM" id="NYU_TERM_116" string="Immunofluorescence" frequency="2" lemma="IMMUNOFLUORESCENCE" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Immunofluorescence </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_301" string="confocal microscopy" frequency="1" lemma="CONFOCAL MICROSCOPY" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">confocal microscopy </ENAMEX>For <ENAMEX type="TERM" id="NYU_TERM_415" string="immunofluorescence staining" frequency="1" lemma="IMMUNOFLUORESCENCE STAINING" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">immunofluorescence staining </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_71" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2</ENAMEX>, the embryos were <ENAMEX type="TERM" id="NYU_TERM_392" string="fixed" frequency="1" lemma="FIXED" lemma_frequency="1" term_pattern_type="chunk-based:['VERB']">fixed </ENAMEX>in 4% <ENAMEX type="TERM" id="NYU_TERM_531" string="paraformaldehyde" frequency="1" lemma="PARAFORMALDEHYDE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">paraformaldehyde </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_532" string="phosphate-buffered saline" frequency="1" lemma="PHOSPHATE-BUFFERED SALINE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'AMBIG_NOUN']">phosphate-buffered saline </ENAMEX>(PBS; pH 7.4) for at least 30 <ENAMEX type="TERM" id="NYU_TERM_469" string="min" frequency="4" lemma="MIN" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV']">min </ENAMEX>at <ENAMEX type="TERM" id="NYU_TERM_579" string="room temperature" frequency="3" lemma="ROOM TEMPERATURE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">room temperature</ENAMEX>. 
5164 After being permeabilized with 0.5% <ENAMEX type="TERM" id="NYU_TERM_223" string="Triton X-100" frequency="3" lemma="TRITON X-100" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">Triton X-100 </ENAMEX>at <ENAMEX type="TERM" id="NYU_TERM_580" string="room temperature" frequency="3" lemma="ROOM TEMPERATURE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">room temperature </ENAMEX>for 20 <ENAMEX type="TERM" id="NYU_TERM_470" string="min" frequency="4" lemma="MIN" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV']">min</ENAMEX>, the embryos were incubated for 1 h in <ENAMEX type="TERM" id="NYU_TERM_277" string="blocking solution" frequency="1" lemma="BLOCKING SOLUTION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">blocking solution </ENAMEX>composed of 1% <ENAMEX type="TERM" id="NYU_TERM_278" string="bovine serum" frequency="1" lemma="BOVINE SERUM" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">bovine serum </ENAMEX>albumin in <ENAMEX type="TERM" id="NYU_TERM_162" string="PBS" frequency="4" lemma="PHOSPHATE BUFFERED SALINE" lemma_frequency="4" term_pattern_type="chunk-based:['PLURAL']">PBS</ENAMEX>, followed by incubation with <ENAMEX type="TERM" id="NYU_TERM_404" string="goat anti-ING2 antibody" frequency="1" lemma="GOAT ANTI-ING2 ANTIBODY" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN', 'NOUN']">goat anti-ING2 antibody </ENAMEX>(dilution, 1:100) overnight at 4 C. 
5433 After three washes in <ENAMEX type="TERM" id="NYU_TERM_163" string="PBS" frequency="4" lemma="PHOSPHATE BUFFERED SALINE" lemma_frequency="4" term_pattern_type="chunk-based:['PLURAL']">PBS </ENAMEX>containing 0.1% <ENAMEX type="TERM" id="NYU_TERM_227" string="Tween" frequency="3" lemma="TWEEN" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">Tween </ENAMEX>20 and 0.01% <ENAMEX type="TERM" id="NYU_TERM_224" string="Triton X-100" frequency="3" lemma="TRITON X-100" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">Triton X-100 </ENAMEX>for 5 <ENAMEX type="TERM" id="NYU_TERM_471" string="min" frequency="4" lemma="MIN" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV']">min </ENAMEX>each, the embryos were labelled with <ENAMEX type="TERM" id="NYU_TERM_393" string="fluorescein isothiocyanate-conjugated rabbit anti-goat IgG" frequency="1" lemma="FLUORESCEIN ISOTHIOCYANATE-CONJUGATED RABBIT ANTI-GOAT IGG" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'AMBIG_NOUN', 'NOUN_OOV', 'NOUN_OOV']">fluorescein isothiocyanate-conjugated rabbit anti-goat IgG </ENAMEX>(dilution, 1:100) for 1 h at <ENAMEX type="TERM" id="NYU_TERM_581" string="room temperature" frequency="3" lemma="ROOM TEMPERATURE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">room temperature</ENAMEX>. 
5660 After three washes in <ENAMEX type="TERM" id="NYU_TERM_164" string="PBS" frequency="4" lemma="PHOSPHATE BUFFERED SALINE" lemma_frequency="4" term_pattern_type="chunk-based:['PLURAL']">PBS </ENAMEX>containing 0.1% <ENAMEX type="TERM" id="NYU_TERM_228" string="Tween" frequency="3" lemma="TWEEN" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">Tween </ENAMEX>20 and 0.01% <ENAMEX type="TERM" id="NYU_TERM_225" string="Triton X-100" frequency="3" lemma="TRITON X-100" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">Triton X-100</ENAMEX>, the embryos were co-stained with <ENAMEX type="TERM" id="NYU_TERM_565" string="propidium iodide" frequency="2" lemma="PROPIDIUM IODIDE" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">propidium iodide </ENAMEX>(10 <ENAMEX type="TERM" id="NYU_TERM_394" string="g/ml" frequency="1" lemma="G/ML" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">g/ml </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_165" string="PBS" frequency="4" lemma="PHOSPHATE BUFFERED SALINE" lemma_frequency="4" term_pattern_type="chunk-based:['PLURAL']">PBS</ENAMEX>), prior to being mounted on glass slides and examined under a <ENAMEX type="TERM" id="NYU_TERM_299" string="confocal laser" frequency="1" lemma="CONFOCAL LASER" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">confocal laser </ENAMEX><ENAMEX type="TERM" id="NYU_TERM_584" string="scanning microscope" frequency="1" lemma="SCANNING MICROSCOPE" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">scanning microscope </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_240" string="Zeiss LSM" frequency="1" lemma="ZEISS LSM" lemma_frequency="1" term_pattern_type="chunk-based:['PERSON_NAME', 'NOUN_OOV']">Zeiss LSM </ENAMEX>510 <ENAMEX type="TERM" id="NYU_TERM_147" string="META" frequency="1" lemma="META" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">META</ENAMEX>, Jena Germany). 
SECTION ID="" TYPE="doc_segment" TITLE="Immunoblotting analysis" START="5937" END="6839"
5937 <ENAMEX type="TERM" id="NYU_TERM_115" string="Immunoblotting analysis" frequency="1" lemma="IMMUNOBLOTTING ANALYSIS" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">Immunoblotting analysis </ENAMEX>The extracted proteins of <ENAMEX type="TERM" id="NYU_TERM_245" string="adult ICR mouse ovaries" frequency="1" lemma="ADULT ICR MOUSE OVARY" lemma_frequency="1" term_pattern_type="chunk-based:['AMBIG_NOUN', 'NOUN_OOV', 'AMBIG_NOUN', 'PLURAL']">adult ICR mouse ovaries </ENAMEX>and morphologically normal 4-cell embryos (150 <ENAMEX type="TERM" id="NYU_TERM_371" string="embryos/sample" frequency="1" lemma="EMBRYOS/SAMPLE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">embryos/sample</ENAMEX>) were separated by <ENAMEX type="TERM" id="NYU_TERM_591" string="sodium dodecyl sulfate polyacrylamide gel electrophoresis" frequency="1" lemma="SODIUM DODECYL SULFATE POLYACRYLAMIDE GEL ELECTROPHORESI" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV', 'NOUN_OOV', 'NOUN_OOV', 'AMBIG_NOUN', 'NOUN_OOV']">sodium dodecyl sulfate polyacrylamide gel electrophoresis </ENAMEX>(SDS-PAGE) and then subsequently transferred to polyvinylidene fluoride membranes via <ENAMEX type="TERM" id="NYU_TERM_342" string="electrophoresis" frequency="1" lemma="ELECTROPHORESI" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">electrophoresis</ENAMEX>. 
6254 Following the transfer, the membranes were blocked in <ENAMEX type="TERM" id="NYU_TERM_216" string="TBST" frequency="2" lemma="TBST" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">TBST </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_215" string="TBS buffer" frequency="1" lemma="TBS BUFFER" lemma_frequency="1" term_pattern_type="chunk-based:['PLURAL', 'NOUN']">TBS buffer </ENAMEX>with 0.1% <ENAMEX type="TERM" id="NYU_TERM_229" string="Tween" frequency="3" lemma="TWEEN" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">Tween </ENAMEX>20) containing 5% skimmed milk for 2 h, followed by incubation overnight at 4 C with <ENAMEX type="TERM" id="NYU_TERM_405" string="goat polyclonal anti-ING2 antibody" frequency="1" lemma="GOAT POLYCLONAL ANTI-ING2 ANTIBODY" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV', 'NOUN', 'NOUN']">goat polyclonal anti-ING2 antibody </ENAMEX>(dilution, 1:500; <ENAMEX type="TERM" id="NYU_TERM_582" string="sc-67646" frequency="1" lemma="SC-67646" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">sc-67646</ENAMEX>, Santa Cruz, Dallas, <ENAMEX type="TERM" id="NYU_TERM_219" string="TX" frequency="1" lemma="TX" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">TX</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_231" string="USA" frequency="6" lemma="USA" lemma_frequency="6" term_pattern_type="chunk-based:['NOUN_OOV']">USA</ENAMEX>). 
6519 After being washed in <ENAMEX type="TERM" id="NYU_TERM_217" string="TBST" frequency="2" lemma="TBST" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">TBST </ENAMEX>three times for 10 <ENAMEX type="TERM" id="NYU_TERM_472" string="min" frequency="4" lemma="MIN" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV']">min </ENAMEX>each, the membranes were incubated for 1 h at 37 C with <ENAMEX type="TERM" id="NYU_TERM_414" string="horseradish peroxidase-conjugated rabbit anti-goat IgG" frequency="1" lemma="HORSERADISH PEROXIDASE-CONJUGATED RABBIT ANTI-GOAT IGG" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV', 'AMBIG_NOUN', 'NOUN_OOV', 'NOUN_OOV']">horseradish peroxidase-conjugated rabbit anti-goat IgG </ENAMEX>(dilution, 1:1000). 
6700 Finally, the membranes were processed and analyzed using an enhanced <ENAMEX type="TERM" id="NYU_TERM_285" string="chemiluminescence detection system" frequency="1" lemma="CHEMILUMINESCENCE DETECTION SYSTEM" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">chemiluminescence detection system </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_5" string="Amersham" frequency="1" lemma="AMERSHAM" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Amersham</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_166" string="Piscataway" frequency="1" lemma="PISCATAWAY" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Piscataway</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_151" string="NJ" frequency="1" lemma="NJ" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">NJ</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_232" string="USA" frequency="6" lemma="USA" lemma_frequency="6" term_pattern_type="chunk-based:['NOUN_OOV']">USA</ENAMEX>). 
SECTION ID="" TYPE="doc_segment" TITLE="Reverse transcription polymerase chain reaction (RT-PCR)" START="6839" END="7785"
6839 Reverse transcription <ENAMEX type="TERM" id="NYU_TERM_536" string="polymerase chain reaction" frequency="1" lemma="POLYMERASE CHAIN REACTION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">polymerase chain reaction </ENAMEX>(RT-PCR) The <ENAMEX type="TERM" id="NYU_TERM_563" string="primer sequences" frequency="1" lemma="PRIMER SEQUENCE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'PLURAL']">primer sequences </ENAMEX>utilized for <ENAMEX type="TERM" id="NYU_TERM_180" string="RT-PCR analysis" frequency="2" lemma="RT-PCR ANALYSIS" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">RT-PCR analysis </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_127" string="Ing2 expression" frequency="4" lemma="ING2 EXPRESSION" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">Ing2 expression </ENAMEX>were as follows: sense, 5 -<ENAMEX type="TERM" id="NYU_TERM_32" string="GGGAGCTGGACAACACCTACCAA-3" frequency="1" lemma="GGGAGCTGGACAACACCTACCAA-3" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">GGGAGCTGGACAACACCTACCAA-3 </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_250" string="antisense" frequency="1" lemma="ANTISENSE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">antisense</ENAMEX>, 5 -<ENAMEX type="TERM" id="NYU_TERM_218" string="TTCGAGCATCTGGGTGACAATC-3" frequency="1" lemma="TTCGAGCATCTGGGTGACAATC-3" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">TTCGAGCATCTGGGTGACAATC-3 </ENAMEX>. 
7065 <ENAMEX type="TERM" id="NYU_TERM_221" string="Total RNA extraction" frequency="1" lemma="TOTAL RNA EXTRACTION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV', 'NOUN']">Total RNA extraction </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_177" string="RT" frequency="1" lemma="RT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">RT </ENAMEX>were performed using an <ENAMEX type="TERM" id="NYU_TERM_176" string="RNeasy Micro Kit" frequency="1" lemma="RNEASY MICRO KIT" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'ADJECTIVE', 'AMBIG_NOUN']">RNeasy Micro Kit </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_172" string="Qiagen" frequency="1" lemma="QIAGEN" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Qiagen</ENAMEX>, Valencia, <ENAMEX type="TERM" id="NYU_TERM_10" string="CA" frequency="2" lemma="CA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">CA</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_233" string="USA" frequency="6" lemma="USA" lemma_frequency="6" term_pattern_type="chunk-based:['NOUN_OOV']">USA</ENAMEX>), according to the<ENAMEX type="TERM" id="NYU_TERM_459" string="manufacturer" frequency="1" lemma="MANUFACTURER" lemma_frequency="1" term_pattern_type="chunk-based:['POSSESS']"> manufacturer</ENAMEX>'s <ENAMEX type="TERM" id="NYU_TERM_438" string="instructions" frequency="1" lemma="INSTRUCTION" lemma_frequency="1" term_pattern_type="chunk-based:['PLURAL']">instructions</ENAMEX>; with <ENAMEX type="TERM" id="NYU_TERM_511" string="oligo-dT" frequency="1" lemma="OLIGO-DT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">oligo-dT </ENAMEX><ENAMEX type="TERM" id="NYU_TERM_256" string="being utilized" frequency="1" lemma="BEING UTILIZED" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">being utilized </ENAMEX>as a primer. 
7251 <ENAMEX type="TERM" id="NYU_TERM_186" string="Real-time PCR analysis" frequency="3" lemma="REAL-TIME PCR ANALYSIS" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV', 'NOUN']">Real-time PCR analysis </ENAMEX>was carried out using a <ENAMEX type="TERM" id="NYU_TERM_30" string="Faststart Universal SYBR Green Master Mix" frequency="1" lemma="FASTSTART UNIVERSAL SYBR GREEN MASTER MIX" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'ADJECTIVE', 'NOUN_OOV', 'AMBIG_NOUN', 'AMBIG_NOUN', 'AMBIG_NOUN']">Faststart Universal SYBR Green Master Mix </ENAMEX>(no. 04913914001, 
7358 Roche Inc., 
7370 Basel, <ENAMEX type="TERM" id="NYU_TERM_214" string="Switzerland" frequency="1" lemma="SWITZERLAND" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Switzerland</ENAMEX>), with an <ENAMEX type="TERM" id="NYU_TERM_2" string="ABI Prism" frequency="1" lemma="ABI PRISM" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ABI Prism </ENAMEX>7500 System (<ENAMEX type="ORGANIZATION" id="NYU_ID_6" string="Applied Biosystems">Applied Biosystems</ENAMEX>, Foster City, <ENAMEX type="TERM" id="NYU_TERM_11" string="CA" frequency="2" lemma="CA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">CA</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_234" string="USA" frequency="6" lemma="USA" lemma_frequency="6" term_pattern_type="chunk-based:['NOUN_OOV']">USA</ENAMEX>). 
7465 <ENAMEX type="CITATION" id="NYU_RELATION_52" nyu_id="E52" cite_class="article_self_cite">We </ENAMEX>processed 15 30 embryos at a time, and the H3f3a gene was utilized as an <ENAMEX type="TERM" id="NYU_TERM_372" string="endogenous control" frequency="1" lemma="ENDOGENOUS CONTROL" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">endogenous control </ENAMEX>(May et al., 2009). 
7580 <ENAMEX type="TERM" id="NYU_TERM_191" string="Relative quantitation" frequency="1" lemma="RELATIVE QUANTITATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">Relative quantitation </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_604" string="target gene expression" frequency="1" lemma="TARGET GENE EXPRESSION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN', 'NOUN']">target gene expression </ENAMEX>was evaluated by the 2 <ENAMEX type="TERM" id="NYU_TERM_18" string="Ct method" frequency="2" lemma="CT METHOD" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">Ct method </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_146" string="Livak" frequency="1" lemma="LIVAK" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Livak </ENAMEX>& <ENAMEX type="TERM" id="NYU_TERM_201" string="Schmittgen" frequency="1" lemma="SCHMITTGEN" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Schmittgen</ENAMEX>, 2001) and data were collated from three <ENAMEX type="TERM" id="NYU_TERM_572" string="replicate experiments" frequency="1" lemma="REPLICATE EXPERIMENT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'AMBIG_PLURAL']">replicate experiments </ENAMEX>utilizing different sets of embryos. 
SECTION ID="" TYPE="doc_segment" TITLE="ING2 MISSION® esiRNA and in vitro culture" START="7785" END="9192"
7785 <ENAMEX type="TERM" id="NYU_TERM_105" string="ING2 MISSION esiRNA" frequency="2" lemma="ING2 MISSION ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN', 'NOUN_OOV']">ING2 MISSION esiRNA </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_422" string="in vitro culture ING2 MISSION esiRNA" frequency="1" lemma="IN VITRO CULTURE ING2 MISSION ESIRNA" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN_OOV', 'NOUN', 'NOUN_OOV']">in vitro culture ING2 MISSION esiRNA </ENAMEX>(EMU022101) and <ENAMEX type="TERM" id="NYU_TERM_499" string="negative control EGFP MISSION esiRNA" frequency="1" lemma="NEGATIVE CONTROL EGFP MISSION ESIRNA" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN_OOV', 'NOUN', 'NOUN_OOV']">negative control EGFP MISSION esiRNA </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_27" string="EHUEGFP" frequency="1" lemma="EHUEGFP" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">EHUEGFP</ENAMEX>) were purchased from <ENAMEX type="TERM" id="NYU_TERM_203" string="Sigma-Aldrich" frequency="2" lemma="SIGMA-ALDRICH" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Sigma-Aldrich </ENAMEX>Inc. 
7952 (<ENAMEX type="TERM" id="NYU_TERM_212" string="St" frequency="2" lemma="ST" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">St</ENAMEX>. Louis, MO, <ENAMEX type="TERM" id="NYU_TERM_235" string="USA" frequency="6" lemma="USA" lemma_frequency="6" term_pattern_type="chunk-based:['NOUN_OOV']">USA</ENAMEX>), which possessed the intellectual property to design and prepare the <ENAMEX type="TERM" id="NYU_TERM_148" string="MISSION esiRNA" frequency="2" lemma="MISSION ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV']">MISSION esiRNA</ENAMEX>. 
8058 The <ENAMEX type="TERM" id="NYU_TERM_126" string="Ing2 cDNA target sequence" frequency="1" lemma="ING2 CDNA TARGET SEQUENCE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN', 'NOUN']">Ing2 cDNA target sequence </ENAMEX>is as follows: 5 -<ENAMEX type="TERM" id="NYU_TERM_1" string="AAACGCCTACAGCAGCATCTCCAGAGAGCGTTAATCAATAGCCAAGAATTGGGAGATGAAAAAATTCAGATTGTCACCCAGATGCTCGAATTGGTGGAGAACCGAGCGAGACAAATGGAGCTGCATTCACAGTGTTTCCAGGATCCTGCTGAAAGTGAGCGAGCCTCAGACAAGTCGAAGATGGATTCCAGTCAACCGGAAAGATCTTCTAGAAGACCTCGAAGACAGAGGACCAGTGAGAGCCGTGACTTATGTCACATGACAAACGGGATTGACGACTGTGATGATCAACCACCGAAAGAAAAGAGATCCAAGTCCGCCAAGAAGAAGAAGCGCTCCAAGGCCAAGCAGGAGAGGGAGGCATCCCCTGTCGAGTTTGCCATCGATCCCAATGAGCCCACCTACTGCTTGTGTAACCAAGTGTCCTACGGGGAGATGATAGGCTG-3" frequency="1" lemma="AAACGCCTACAGCAGCATCTCCAGAGAGCGTTAATCAATAGCCAAGAATTGGGAGATGAAAAAATTCAGATTGTCACCCAGATGCTCGAATTGGTGGAGAACCGAGCGAGACAAATGGAGCTGCATTCACAGTGTTTCCAGGATCCTGCTGAAAGTGAGCGAGCCTCAGACAAGTCGAAGATGGATTCCAGTCAACCGGAAAGATCTTCTAGAAGACCTCGAAGACAGAGGACCAGTGAGAGCCGTGACTTATGTCACATGACAAACGGGATTGACGACTGTGATGATCAACCACCGAAAGAAAAGAGATCCAAGTCCGCCAAGAAGAAGAAGCGCTCCAAGGCCAAGCAGGAGAGGGAGGCATCCCCTGTCGAGTTTGCCATCGATCCCAATGAGCCCACCTACTGCTTGTGTAACCAAGTGTCCTACGGGGAGATGATAGGCTG-3" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">AAACGCCTACAGCAGCATCTCCAGAGAGCGTTAATCAATAGCCAAGAATTGGGAGATGAAAAAATTCAGATTGTCACCCAGATGCTCGAATTGGTGGAGAACCGAGCGAGACAAATGGAGCTGCATTCACAGTGTTTCCAGGATCCTGCTGAAAGTGAGCGAGCCTCAGACAAGTCGAAGATGGATTCCAGTCAACCGGAAAGATCTTCTAGAAGACCTCGAAGACAGAGGACCAGTGAGAGCCGTGACTTATGTCACATGACAAACGGGATTGACGACTGTGATGATCAACCACCGAAAGAAAAGAGATCCAAGTCCGCCAAGAAGAAGAAGCGCTCCAAGGCCAAGCAGGAGAGGGAGGCATCCCCTGTCGAGTTTGCCATCGATCCCAATGAGCCCACCTACTGCTTGTGTAACCAAGTGTCCTACGGGGAGATGATAGGCTG-3 </ENAMEX>. 
8557 <ENAMEX type="TERM" id="NYU_TERM_149" string="MISSION esiRNA" frequency="2" lemma="MISSION ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV']">MISSION esiRNA </ENAMEX>are a <ENAMEX type="TERM" id="NYU_TERM_409" string="heterogeneous mixture" frequency="1" lemma="HETEROGENEOUS MIXTURE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">heterogeneous mixture </ENAMEX>of siRNAs that all target the same <ENAMEX type="TERM" id="NYU_TERM_458" string="mRNA sequence" frequency="1" lemma="MRNA SEQUENCE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">mRNA sequence</ENAMEX>. 
8650 These multiple silencing triggers lead to lower <ENAMEX type="TERM" id="NYU_TERM_510" string="off-target effects" frequency="1" lemma="OFF-TARGET EFFECT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'AMBIG_PLURAL']">off-target effects </ENAMEX>than single or pooled <ENAMEX type="TERM" id="NYU_TERM_586" string="siRNAs" frequency="1" lemma="SIRNA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">siRNAs</ENAMEX>, and exert highly specific and effective <ENAMEX type="TERM" id="NYU_TERM_403" string="gene silencing" frequency="1" lemma="GENE SILENCING" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">gene silencing</ENAMEX>. 
8803 The <ENAMEX type="TERM" id="NYU_TERM_297" string="concentration" frequency="1" lemma="CONCENTRATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">concentration </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_106" string="ING2 MISSION esiRNA" frequency="2" lemma="ING2 MISSION ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN', 'NOUN_OOV']">ING2 MISSION esiRNA </ENAMEX>was 200 <ENAMEX type="TERM" id="NYU_TERM_504" string="ng" frequency="1" lemma="NG" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">ng</ENAMEX>/ l in <ENAMEX type="TERM" id="NYU_TERM_506" string="nuclease-free TE buffer" frequency="1" lemma="NUCLEASE-FREE TE BUFFER" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'NOUN']">nuclease-free TE buffer </ENAMEX>(10 <ENAMEX type="TERM" id="NYU_TERM_456" string="mM Tris-HCl" frequency="1" lemma="MM TRIS-HCL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">mM Tris-HCl</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_529" string="pH" frequency="1" lemma="PH" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">pH </ENAMEX>8.0, 1 <ENAMEX type="TERM" id="NYU_TERM_455" string="mM EDTA" frequency="1" lemma="MM EDTA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV']">mM EDTA</ENAMEX>). 
8922 Approximately 10 <ENAMEX type="TERM" id="NYU_TERM_534" string="pl" frequency="1" lemma="PL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">pl </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_433" string="individual esiRNA" frequency="1" lemma="INDIVIDUAL ESIRNA" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">individual esiRNA </ENAMEX>was microinjected into the <ENAMEX type="TERM" id="NYU_TERM_306" string="cytoplasm" frequency="1" lemma="CYTOPLASM" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">cytoplasm </ENAMEX>of the <ENAMEX type="TERM" id="NYU_TERM_622" string="zygotes" frequency="6" lemma="ZYGOTE" lemma_frequency="8" term_pattern_type="chunk-based:['PLURAL']">zygotes</ENAMEX>, which were cultured in <ENAMEX type="TERM" id="NYU_TERM_14" string="CZB medium" frequency="2" lemma="CZB MEDIUM" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">CZB medium </ENAMEX>and subjected to further observation. 
9088 The <ENAMEX type="TERM" id="NYU_TERM_327" string="developmental progress" frequency="1" lemma="DEVELOPMENTAL PROGRESS" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental progress </ENAMEX>of each group was observed and analyzed using a <ENAMEX type="TERM" id="NYU_TERM_156" string="Nikon TE2000-S" frequency="1" lemma="NIKON TE2000-S" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'PLURAL']">Nikon TE2000-S </ENAMEX><ENAMEX type="TERM" id="NYU_TERM_468" string="microscope" frequency="1" lemma="MICROSCOPE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">microscope</ENAMEX>. 
SECTION ID="" TYPE="doc_segment" TITLE="Statistical analysis" START="9192" END="9628"
9192 <ENAMEX type="TERM" id="NYU_TERM_213" string="Statistical analysis" frequency="1" lemma="STATISTICAL ANALYSIS" lemma_frequency="3" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">Statistical analysis </ENAMEX>Each experiment was repeated at least three times. 
9265 Before <ENAMEX type="TERM" id="NYU_TERM_595" string="statistical analysis" frequency="2" lemma="STATISTICAL ANALYSIS" lemma_frequency="3" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">statistical analysis</ENAMEX>, all percentage data were subjected to <ENAMEX type="TERM" id="NYU_TERM_253" string="arc-sine transformation" frequency="1" lemma="ARC-SINE TRANSFORMATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">arc-sine transformation</ENAMEX>. 
9357 Data were analyzed with <ENAMEX type="TERM" id="NYU_TERM_513" string="one-way analysis" frequency="1" lemma="ONE-WAY ANALYSIS" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">one-way analysis </ENAMEX>of variance, <ENAMEX type="TERM" id="NYU_TERM_530" string="paired Student" frequency="1" lemma="PAIRED STUDENT" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'POSSESS']">paired Student</ENAMEX>'s <ENAMEX type="TERM" id="NYU_TERM_603" string="t-test" frequency="1" lemma="T-TEST" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">t-test </ENAMEX>and the <ENAMEX type="TERM" id="NYU_TERM_286" string="chi-squared test" frequency="1" lemma="CHI-SQUARED TEST" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">chi-squared test</ENAMEX>, using <ENAMEX type="TERM" id="NYU_TERM_198" string="SPSS software" frequency="1" lemma="SPSS SOFTWARE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">SPSS software </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_197" string="SPSS" frequency="1" lemma="STATISTICAL PACKAGE FOR SOCIAL SCIENCE," lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">SPSS </ENAMEX>Inc., 
9493 <ENAMEX type="TERM" id="NYU_TERM_16" string="Chicago" frequency="1" lemma="CHICAGO" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Chicago</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_64" string="IL" frequency="1" lemma="IL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">IL</ENAMEX>). 
9507 Data are expressed as mean standard deviation (SD), with a <ENAMEX type="TERM" id="NYU_TERM_161" string="P-value" frequency="1" lemma="P-VALUE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">P-value </ENAMEX>0.05 being considered statistically significant. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="9628" END="9637"
9628 Results 
SECTION ID="" TYPE="doc_segment" TITLE="The expression of ING2 during mouse preimplantation development" START="9637" END="11881"
9637 The expression of <ENAMEX type="TERM" id="NYU_TERM_72" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>during mouse <ENAMEX type="TERM" id="NYU_TERM_541" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development </ENAMEX><ENAMEX type="CITATION" id="NYU_RELATION_53" nyu_id="E53" cite_class="article_self_cite">We </ENAMEX>analyzed the <ENAMEX type="TERM" id="NYU_TERM_386" string="expression profile" frequency="1" lemma="EXPRESSION PROFILE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">expression profile </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_122" string="Ing2" frequency="4" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">Ing2 </ENAMEX>at each stage of mouse <ENAMEX type="TERM" id="NYU_TERM_556" string="preimplantation embryonic development" frequency="7" lemma="PREIMPLANTATION EMBRYONIC DEVELOPMENT" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">preimplantation embryonic development</ENAMEX>. 
9807 The <ENAMEX type="TERM" id="NYU_TERM_183" string="RT-PCR data" frequency="1" lemma="RT-PCR DATA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">RT-PCR data </ENAMEX>confirmed expression of <ENAMEX type="TERM" id="NYU_TERM_123" string="Ing2" frequency="4" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">Ing2 </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_495" string="mouse preimplantation embryos" frequency="1" lemma="MOUSE PREIMPLANTATION EMBRYO" lemma_frequency="2" term_pattern_type="chunk-based:['AMBIG_NOUN', 'NOUN_OOV', 'PLURAL']">mouse preimplantation embryos </ENAMEX>(Fig. 1A), and further analysis <ENAMEX type="TERM" id="NYU_TERM_576" string="revealed variation" frequency="1" lemma="REVEALED VARIATION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">revealed variation </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_384" string="expression levels" frequency="1" lemma="EXPRESSION LEVEL" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'AMBIG_PLURAL']">expression levels </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_124" string="Ing2" frequency="4" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">Ing2 </ENAMEX>at different <ENAMEX type="TERM" id="NYU_TERM_363" string="embryonic developmental stages" frequency="2" lemma="EMBRYONIC DEVELOPMENTAL STAGE" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'AMBIG_PLURAL']">embryonic developmental stages </ENAMEX>(Fig. 1
10016 B). 
10020 Most notably, <ENAMEX type="TERM" id="NYU_TERM_128" string="Ing2 expression" frequency="4" lemma="ING2 EXPRESSION" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">Ing2 expression </ENAMEX>rapidly increased from the 2-cell to 4-cell <ENAMEX type="TERM" id="NYU_TERM_292" string="cleavage-stage" frequency="1" lemma="CLEAVAGE-STAGE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">cleavage-stage</ENAMEX>. 
10110 This suggests that <ENAMEX type="TERM" id="NYU_TERM_125" string="Ing2" frequency="4" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">Ing2 </ENAMEX>may be a crucial <ENAMEX type="TERM" id="NYU_TERM_476" string="modulator" frequency="2" lemma="MODULATOR" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">modulator </ENAMEX>of early <ENAMEX type="TERM" id="NYU_TERM_362" string="embryonic development genes" frequency="1" lemma="EMBRYONIC DEVELOPMENT GENE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'PLURAL']">embryonic development genes</ENAMEX>. 
10199 Western blot analysis utilizing an <ENAMEX type="TERM" id="NYU_TERM_248" string="anti-ING2 antibody" frequency="2" lemma="ANTI-ING2 ANTIBODY" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">anti-ING2 antibody </ENAMEX>revealed an <ENAMEX type="TERM" id="NYU_TERM_379" string="exclusive band" frequency="1" lemma="EXCLUSIVE BAND" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">exclusive band </ENAMEX>at the expected <ENAMEX type="TERM" id="NYU_TERM_478" string="molecular mass" frequency="1" lemma="MOLECULAR MASS" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">molecular mass </ENAMEX>of 33 <ENAMEX type="TERM" id="NYU_TERM_442" string="kDa" frequency="1" lemma="KDA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">kDa</ENAMEX>, for both the <ENAMEX type="TERM" id="NYU_TERM_490" string="mouse ovary" frequency="2" lemma="MOUSE OVARY" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">mouse ovary </ENAMEX>and 4-cell <ENAMEX type="TERM" id="NYU_TERM_344" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo </ENAMEX>(Fig. 2
10372 A). 
10377 Figure 1 (A) <ENAMEX type="TERM" id="NYU_TERM_193" string="SDS-PAGE gel" frequency="1" lemma="SDS-PAGE GEL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">SDS-PAGE gel </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_179" string="RT-PCR amplification" frequency="1" lemma="RT-PCR AMPLIFICATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">RT-PCR amplification </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_132" string="Ing2 mRNA transcripts" frequency="1" lemma="ING2 MRNA TRANSCRIPT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'TECH_ADJECTIVE', 'PLURAL']">Ing2 mRNA transcripts </ENAMEX>extracted at different <ENAMEX type="TERM" id="NYU_TERM_369" string="embryonic stages" frequency="2" lemma="EMBRYONIC STAGE" lemma_frequency="3" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">embryonic stages</ENAMEX>. 
10494 H3f3a was utilized as the <ENAMEX type="TERM" id="NYU_TERM_373" string="endogenous reference gene" frequency="1" lemma="ENDOGENOUS REFERENCE GENE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">endogenous reference gene</ENAMEX>. 
10547 Lanes 1, 2, 3, 4, 5 corresponds to zygote, 2-cell <ENAMEX type="TERM" id="NYU_TERM_345" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo</ENAMEX>, 4-cell <ENAMEX type="TERM" id="NYU_TERM_346" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_489" string="morula-stage embryo" frequency="1" lemma="MORULA-STAGE EMBRYO" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">morula-stage embryo </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_275" string="blastocyst-stage embryo" frequency="1" lemma="BLASTOCYST-STAGE EMBRYO" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">blastocyst-stage embryo </ENAMEX>respectively. (
10683 B) <ENAMEX type="TERM" id="NYU_TERM_187" string="Real-time PCR analysis" frequency="3" lemma="REAL-TIME PCR ANALYSIS" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV', 'NOUN']">Real-time PCR analysis </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_131" string="Ing2 mRNA expression patterns" frequency="1" lemma="ING2 MRNA EXPRESSION PATTERN" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'TECH_ADJECTIVE', 'NOUN', 'AMBIG_PLURAL']">Ing2 mRNA expression patterns </ENAMEX>at different <ENAMEX type="TERM" id="NYU_TERM_370" string="embryonic stages" frequency="2" lemma="EMBRYONIC STAGE" lemma_frequency="3" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">embryonic stages </ENAMEX>during mouse <ENAMEX type="TERM" id="NYU_TERM_542" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development</ENAMEX>. 
10814 The <ENAMEX type="TERM" id="NYU_TERM_381" string="expression level" frequency="2" lemma="EXPRESSION LEVEL" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">expression level </ENAMEX>was calculated from the <ENAMEX type="TERM" id="NYU_TERM_305" string="cycle threshold" frequency="1" lemma="CYCLE THRESHOLD" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">cycle threshold </ENAMEX>(Ct) values by the 2 <ENAMEX type="TERM" id="NYU_TERM_19" string="Ct method" frequency="2" lemma="CT METHOD" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">Ct method</ENAMEX>. 
10909 The <ENAMEX type="TERM" id="NYU_TERM_279" string="calibration sample" frequency="3" lemma="CALIBRATION SAMPLE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">calibration sample </ENAMEX>was embryos at the <ENAMEX type="TERM" id="NYU_TERM_619" string="zygote stage" frequency="1" lemma="ZYGOTE STAGE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">zygote stage</ENAMEX>. 
10965 Bar graphs indicate mean standard deviation (SD) of three <ENAMEX type="TERM" id="NYU_TERM_380" string="experimental replicates" frequency="1" lemma="EXPERIMENTAL REPLICATE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">experimental replicates</ENAMEX>. 
11052 Figure 2 (A) Western blot with the <ENAMEX type="TERM" id="NYU_TERM_247" string="anti ING2 antibody" frequency="1" lemma="ANTI ING2 ANTIBODY" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV', 'NOUN']">anti ING2 antibody </ENAMEX>showed only one distinct band at the predicted <ENAMEX type="TERM" id="NYU_TERM_480" string="molecular weight" frequency="1" lemma="MOLECULAR WEIGHT" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">molecular weight </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_110" string="ING2 protein" frequency="2" lemma="ING2 PROTEIN" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ING2 protein </ENAMEX>(33 <ENAMEX type="TERM" id="NYU_TERM_441" string="kD" frequency="1" lemma="KD" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">kD</ENAMEX>), for both the <ENAMEX type="TERM" id="NYU_TERM_491" string="mouse ovary" frequency="2" lemma="MOUSE OVARY" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">mouse ovary </ENAMEX>and 4-cell <ENAMEX type="TERM" id="NYU_TERM_347" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo</ENAMEX>. (
11241 B) <ENAMEX type="TERM" id="NYU_TERM_118" string="Immunofluorescence staining" frequency="1" lemma="IMMUNOFLUORESCENCE STAINING" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">Immunofluorescence staining </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_73" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>and nuclear <ENAMEX type="TERM" id="NYU_TERM_21" string="DNA" frequency="1" lemma="DNA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">DNA </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_561" string="preimplantation embryos" frequency="2" lemma="PREIMPLANTATION EMBRYO" lemma_frequency="4" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">preimplantation embryos </ENAMEX>with specific <ENAMEX type="TERM" id="NYU_TERM_249" string="anti-ING2 antibody" frequency="2" lemma="ANTI-ING2 ANTIBODY" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">anti-ING2 antibody </ENAMEX>(green, a f ) and <ENAMEX type="TERM" id="NYU_TERM_566" string="propidium iodide" frequency="2" lemma="PROPIDIUM IODIDE" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">propidium iodide </ENAMEX>(red, a f ) respectively. <ENAMEX type="TERM" id="NYU_TERM_618" string="zygote" frequency="1" lemma="ZYGOTE" lemma_frequency="8" term_pattern_type="chunk-based:['NOUN_OOV']">zygote</ENAMEX>, approximately 21 h after human <ENAMEX type="TERM" id="NYU_TERM_288" string="chorionic gonadotropin" frequency="2" lemma="CHORIONIC GONADOTROPIN" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">chorionic gonadotropin </ENAMEX>(HCG) <ENAMEX type="TERM" id="NYU_TERM_437" string="injection" frequency="2" lemma="INJECTION" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN']">injection </ENAMEX>(a , a ); 2-cell <ENAMEX type="TERM" id="NYU_TERM_348" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo</ENAMEX>, approximately 45 h after <ENAMEX type="TERM" id="NYU_TERM_38" string="HCG injection" frequency="4" lemma="HCG INJECTION" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">HCG injection </ENAMEX>(b , b ); 4- to 8-cell <ENAMEX type="TERM" id="NYU_TERM_349" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo</ENAMEX>, approximately 58 h after <ENAMEX type="TERM" id="NYU_TERM_39" string="HCG injection" frequency="4" lemma="HCG INJECTION" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">HCG injection </ENAMEX>(c , c , d , d ); <ENAMEX type="TERM" id="NYU_TERM_486" string="morula" frequency="5" lemma="MORULA" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV']">morula</ENAMEX>, approximately 78 h after <ENAMEX type="TERM" id="NYU_TERM_40" string="HCG injection" frequency="4" lemma="HCG INJECTION" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">HCG injection </ENAMEX>(e, e ) and <ENAMEX type="TERM" id="NYU_TERM_260" string="blastocyst" frequency="3" lemma="BLASTOCYST" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">blastocyst</ENAMEX>, approximately 96 h after <ENAMEX type="TERM" id="NYU_TERM_41" string="HCG injection" frequency="4" lemma="HCG INJECTION" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">HCG injection </ENAMEX>(f , f ). 
11778 <ENAMEX type="TERM" id="NYU_TERM_199" string="Scale bar" frequency="2" lemma="SCALE BAR" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">Scale bar</ENAMEX>: 2 m. (C) Unstained 2-cell <ENAMEX type="TERM" id="NYU_TERM_350" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo </ENAMEX>was utilized as the <ENAMEX type="TERM" id="NYU_TERM_498" string="negative control" frequency="1" lemma="NEGATIVE CONTROL" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">negative control</ENAMEX>. 
11861 <ENAMEX type="TERM" id="NYU_TERM_200" string="Scale bar" frequency="2" lemma="SCALE BAR" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">Scale bar</ENAMEX>: 1 m. 
SECTION ID="" TYPE="doc_segment" TITLE="The localization of ING2 during mouse preimplantation development" START="11881" END="12751"
11881 The <ENAMEX type="TERM" id="NYU_TERM_448" string="localization" frequency="3" lemma="LOCALIZATION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN']">localization </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_74" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>during <ENAMEX type="TERM" id="NYU_TERM_492" string="mouse preimplantation development Laser" frequency="1" lemma="MOUSE PREIMPLANTATION DEVELOPMENT LASER" lemma_frequency="1" term_pattern_type="chunk-based:['AMBIG_NOUN', 'NOUN_OOV', 'NOUN', 'AMBIG_NOUN']">mouse preimplantation development Laser </ENAMEX><ENAMEX type="TERM" id="NYU_TERM_583" string="scanning confocal microscope" frequency="1" lemma="SCANNING CONFOCAL MICROSCOPE" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN_OOV', 'NOUN']">scanning confocal microscope </ENAMEX>was used to analyze <ENAMEX type="TERM" id="NYU_TERM_597" string="subcellular localization" frequency="1" lemma="SUBCELLULAR LOCALIZATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">subcellular localization </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_111" string="ING2 protein" frequency="2" lemma="ING2 PROTEIN" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ING2 protein </ENAMEX>at different stages of the <ENAMEX type="TERM" id="NYU_TERM_494" string="mouse preimplantation embryo" frequency="1" lemma="MOUSE PREIMPLANTATION EMBRYO" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV', 'NOUN']">mouse preimplantation embryo</ENAMEX>. 
12101 There was <ENAMEX type="TERM" id="NYU_TERM_427" string="increased expression" frequency="2" lemma="INCREASED EXPRESSION" lemma_frequency="2" term_pattern_type="chunk-based:['VERB', 'NOUN']">increased expression </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_75" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>from the 2-cell embryo stage onwards with <ENAMEX type="TERM" id="NYU_TERM_431" string="increasing accumulation" frequency="1" lemma="INCREASING ACCUMULATION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">increasing accumulation </ENAMEX>within the nucleus beginning from the 4-cell embryo stage (Fig. 2
12271 B). 
12275 Unstained 2-cell embryos were utilized as the <ENAMEX type="TERM" id="NYU_TERM_502" string="negative controls" frequency="1" lemma="NEGATIVE CONTROL" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">negative controls </ENAMEX>(Fig. 2C). 
12350 The <ENAMEX type="TERM" id="NYU_TERM_417" string="immunostaining result" frequency="1" lemma="IMMUNOSTAINING RESULT" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">immunostaining result </ENAMEX>is consistent with the <ENAMEX type="TERM" id="NYU_TERM_457" string="mRNA expression patterns" frequency="1" lemma="MRNA EXPRESSION PATTERN" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'AMBIG_PLURAL']">mRNA expression patterns </ENAMEX>revealed by <ENAMEX type="TERM" id="NYU_TERM_178" string="RT-PCR" frequency="1" lemma="REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">RT-PCR</ENAMEX>. 
12444 <ENAMEX type="TERM" id="NYU_TERM_104" string="ING2 C-terminal" frequency="1" lemma="ING2 C-TERMINAL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ING2 C-terminal </ENAMEX>contains a nuclear <ENAMEX type="TERM" id="NYU_TERM_454" string="localization sequence" frequency="1" lemma="LOCALIZATION SEQUENCE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">localization sequence </ENAMEX>(NLS) domain, which possesses three nuclear <ENAMEX type="TERM" id="NYU_TERM_605" string="targeting sequences" frequency="1" lemma="TARGETING SEQUENCE" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'PLURAL']">targeting sequences </ENAMEX>(NTS) that target to the <ENAMEX type="TERM" id="NYU_TERM_507" string="nucleolus" frequency="1" lemma="NUCLEOLUS" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">nucleolus</ENAMEX>. 
12601 Hence, the nuclear <ENAMEX type="TERM" id="NYU_TERM_449" string="localization" frequency="3" lemma="LOCALIZATION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN']">localization </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_76" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>thus suggests that <ENAMEX type="TERM" id="NYU_TERM_77" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>may have <ENAMEX type="TERM" id="NYU_TERM_443" string="key functions" frequency="1" lemma="KEY FUNCTION" lemma_frequency="1" term_pattern_type="chunk-based:['AMBIG_NOUN', 'AMBIG_PLURAL']">key functions </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_570" string="regulating gene transcription" frequency="1" lemma="REGULATING GENE TRANSCRIPTION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN', 'NOUN']">regulating gene transcription </ENAMEX>or <ENAMEX type="TERM" id="NYU_TERM_291" string="chromosome modification" frequency="1" lemma="CHROMOSOME MODIFICATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">chromosome modification</ENAMEX>. 
SECTION ID="" TYPE="doc_segment" TITLE="Knockdown of ING2 retards embryonic development in vitro" START="12751" END="14910"
12751 <ENAMEX type="TERM" id="NYU_TERM_141" string="Knockdown" frequency="1" lemma="KNOCKDOWN" lemma_frequency="1" term_pattern_type="chunk-based:['ADJECTIVE']">Knockdown </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_78" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>retards <ENAMEX type="TERM" id="NYU_TERM_358" string="embryonic development" frequency="6" lemma="EMBRYONIC DEVELOPMENT" lemma_frequency="6" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">embryonic development </ENAMEX>in vitro To investigate the role of <ENAMEX type="TERM" id="NYU_TERM_79" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>in mouse embryos, <ENAMEX type="TERM" id="NYU_TERM_623" string="zygotes" frequency="6" lemma="ZYGOTE" lemma_frequency="8" term_pattern_type="chunk-based:['PLURAL']">zygotes </ENAMEX>were microinjected with <ENAMEX type="TERM" id="NYU_TERM_587" string="sigma MISSION esiRNA" frequency="2" lemma="SIGMA MISSION ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN_OOV']">sigma MISSION esiRNA </ENAMEX>against <ENAMEX type="TERM" id="NYU_TERM_80" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2</ENAMEX>. 
12926 <ENAMEX type="TERM" id="NYU_TERM_243" string="Zygotes microinjected" frequency="1" lemma="ZYGOTES MICROINJECTED" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">Zygotes microinjected </ENAMEX>with <ENAMEX type="TERM" id="NYU_TERM_589" string="sigma negative MISSION esiRNA" frequency="1" lemma="SIGMA NEGATIVE MISSION ESIRNA" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN', 'NOUN_OOV']">sigma negative MISSION esiRNA </ENAMEX>served as controls. 
13003 <ENAMEX type="TERM" id="NYU_TERM_184" string="Real-time PCR" frequency="2" lemma="REAL-TIME PCR" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV']">Real-time PCR </ENAMEX>showed that the <ENAMEX type="TERM" id="NYU_TERM_382" string="expression level" frequency="2" lemma="EXPRESSION LEVEL" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">expression level </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_81" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>was significantly reduced (Fig. 3A) upon <ENAMEX type="TERM" id="NYU_TERM_464" string="microinjection" frequency="3" lemma="MICROINJECTION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">microinjection </ENAMEX>with the esiRNA, and this was further confirmed by reduced expression at the <ENAMEX type="TERM" id="NYU_TERM_567" string="protein level" frequency="2" lemma="PROTEIN LEVEL" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">protein level </ENAMEX>detected by <ENAMEX type="TERM" id="NYU_TERM_416" string="immunostaining" frequency="1" lemma="IMMUNOSTAINING" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">immunostaining </ENAMEX>(Fig. 3
13239 B). 
13243 Inverted light microscopy was used to track the development of the treated embryos that were cultured up to the <ENAMEX type="TERM" id="NYU_TERM_267" string="blastocyst stage" frequency="7" lemma="BLASTOCYST STAGE" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst stage </ENAMEX>(Fig. 3
13379 C). 
13383 Notably, <ENAMEX type="TERM" id="NYU_TERM_596" string="statistical analysis" frequency="2" lemma="STATISTICAL ANALYSIS" lemma_frequency="3" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">statistical analysis </ENAMEX>showed significant differences in the ratio of embryos that developed to the 4-cell, <ENAMEX type="TERM" id="NYU_TERM_487" string="morula" frequency="5" lemma="MORULA" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV']">morula </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_268" string="blastocyst stage" frequency="7" lemma="BLASTOCYST STAGE" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst stage </ENAMEX>between the treated group (n = 150) and the <ENAMEX type="TERM" id="NYU_TERM_500" string="negative control group" frequency="2" lemma="NEGATIVE CONTROL GROUP" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">negative control group </ENAMEX>(n = 132): 82.7% vs. 94.7% (P 0.05), 67.3% vs. 89.4% (P 0.05), 48.7% vs. 75.8% (P 0.01) (
13688 Table 1). 
13698 This demonstrated that <ENAMEX type="TERM" id="NYU_TERM_109" string="ING2 expression" frequency="1" lemma="ING2 EXPRESSION" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ING2 expression </ENAMEX>was essential to mouse <ENAMEX type="TERM" id="NYU_TERM_557" string="preimplantation embryonic development" frequency="7" lemma="PREIMPLANTATION EMBRYONIC DEVELOPMENT" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">preimplantation embryonic development</ENAMEX>. 
13801 Table 1 The <ENAMEX type="TERM" id="NYU_TERM_320" string="developmental competence" frequency="1" lemma="DEVELOPMENTAL COMPETENCE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental competence </ENAMEX>of embryos that were microinjected with <ENAMEX type="TERM" id="NYU_TERM_113" string="ING2-specific esiRNA" frequency="2" lemma="ING2-SPECIFIC ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV']">ING2-specific esiRNA </ENAMEX>or <ENAMEX type="TERM" id="NYU_TERM_503" string="negative esiRNA" frequency="1" lemma="NEGATIVE ESIRNA" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">negative esiRNA </ENAMEX>was evaluated by determining the ratios of <ENAMEX type="TERM" id="NYU_TERM_462" string="microinjected embryos" frequency="1" lemma="MICROINJECTED EMBRYO" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">microinjected embryos </ENAMEX>progressing to various <ENAMEX type="TERM" id="NYU_TERM_332" string="developmental stages" frequency="3" lemma="DEVELOPMENTAL STAGE" lemma_frequency="4" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">developmental stages </ENAMEX>No. of embryos (%) <ENAMEX type="TERM" id="NYU_TERM_222" string="Treatment Total" frequency="1" lemma="TREATMENT TOTAL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'AMBIG_NOUN']">Treatment Total </ENAMEX>4-cell <ENAMEX type="TERM" id="NYU_TERM_150" string="Morula Blastocyst Ing2-esiRNA" frequency="1" lemma="MORULA BLASTOCYST ING2-ESIRNA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'NOUN']">Morula Blastocyst Ing2-esiRNA </ENAMEX>150 124 (82.7) 101 (67.3) 73 (48.7) 
14149 Control 132 125 (94.7)** 118 (89.4)** 100 (75.8)** P 0.01 (vs. control). 
14236 Figure 3 <ENAMEX type="TERM" id="NYU_TERM_242" string="Zygotes" frequency="1" lemma="ZYGOTE" lemma_frequency="8" term_pattern_type="chunk-based:['PLURAL']">Zygotes </ENAMEX>were microinjected with <ENAMEX type="TERM" id="NYU_TERM_82" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>specific <ENAMEX type="TERM" id="NYU_TERM_588" string="sigma MISSION esiRNA" frequency="2" lemma="SIGMA MISSION ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN_OOV']">sigma MISSION esiRNA</ENAMEX>. (A) <ENAMEX type="TERM" id="NYU_TERM_185" string="Real-time PCR" frequency="2" lemma="REAL-TIME PCR" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV']">Real-time PCR </ENAMEX><ENAMEX type="TERM" id="NYU_TERM_318" string="detected down-regulation" frequency="1" lemma="DETECTED DOWN-REGULATION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">detected down-regulation </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_129" string="Ing2 expression" frequency="4" lemma="ING2 EXPRESSION" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">Ing2 expression</ENAMEX>. 
14377 The control and <ENAMEX type="TERM" id="NYU_TERM_280" string="calibration sample" frequency="3" lemma="CALIBRATION SAMPLE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">calibration sample </ENAMEX>was untreated <ENAMEX type="TERM" id="NYU_TERM_624" string="zygotes" frequency="6" lemma="ZYGOTE" lemma_frequency="8" term_pattern_type="chunk-based:['PLURAL']">zygotes</ENAMEX>. 
14435 <ENAMEX type="TERM" id="NYU_TERM_29" string="Error bars" frequency="1" lemma="ERROR BAR" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'AMBIG_PLURAL']">Error bars </ENAMEX>represent standard deviation (SD) (*P 0.05). (B) <ENAMEX type="TERM" id="NYU_TERM_117" string="Immunofluorescence" frequency="2" lemma="IMMUNOFLUORESCENCE" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Immunofluorescence </ENAMEX>staining confirmed <ENAMEX type="TERM" id="NYU_TERM_313" string="decreased ING2 protein expression levels" frequency="1" lemma="DECREASED ING2 PROTEIN EXPRESSION LEVEL" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN_OOV', 'NOUN', 'NOUN', 'AMBIG_PLURAL']">decreased ING2 protein expression levels </ENAMEX>in the <ENAMEX type="TERM" id="NYU_TERM_463" string="microinjected mouse embryos" frequency="1" lemma="MICROINJECTED MOUSE EMBRYO" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'AMBIG_NOUN', 'PLURAL']">microinjected mouse embryos</ENAMEX>. (
14613 C) After <ENAMEX type="TERM" id="NYU_TERM_625" string="zygotes" frequency="6" lemma="ZYGOTE" lemma_frequency="8" term_pattern_type="chunk-based:['PLURAL']">zygotes </ENAMEX>were microinjected with <ENAMEX type="TERM" id="NYU_TERM_83" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>specific <ENAMEX type="TERM" id="NYU_TERM_377" string="esiRNA" frequency="2" lemma="ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">esiRNA</ENAMEX>, the ratio of embryos that progressed to later <ENAMEX type="TERM" id="NYU_TERM_364" string="embryonic developmental stages" frequency="2" lemma="EMBRYONIC DEVELOPMENTAL STAGE" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'AMBIG_PLURAL']">embryonic developmental stages </ENAMEX>was evaluated. 
14768 The depletion of <ENAMEX type="TERM" id="NYU_TERM_84" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>led to <ENAMEX type="TERM" id="NYU_TERM_328" string="developmental retardation" frequency="1" lemma="DEVELOPMENTAL RETARDATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental retardation</ENAMEX>. 
14824 The results of five independent experiments were collated (*P 0.05, **P 0.01). 
SECTION ID="" TYPE="doc_segment" TITLE="RNAi-mediated ablation of Ing2 results in increased p21 and decreased HDAC1 expression" START="14910" END="16537"
14910 <ENAMEX type="TERM" id="NYU_TERM_174" string="RNAi-mediated ablation" frequency="1" lemma="RNAI-MEDIATED ABLATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV']">RNAi-mediated ablation </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_133" string="Ing2 results" frequency="1" lemma="ING2 RESULT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'AMBIG_PLURAL']">Ing2 results </ENAMEX>in increased <ENAMEX type="TERM" id="NYU_TERM_514" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21 </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_312" string="decreased HDAC1 expression" frequency="1" lemma="DECREASED HDAC1 EXPRESSION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN_OOV', 'NOUN']">decreased HDAC1 expression </ENAMEX>To gain a better understanding of the basis for the <ENAMEX type="TERM" id="NYU_TERM_321" string="developmental delay" frequency="2" lemma="DEVELOPMENTAL DELAY" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental delay </ENAMEX>of the <ENAMEX type="TERM" id="NYU_TERM_135" string="Ing2-depleted embryos" frequency="2" lemma="ING2-DEPLETED EMBRYO" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'PLURAL']">Ing2-depleted embryos</ENAMEX>, <ENAMEX type="CITATION" id="NYU_RELATION_54" nyu_id="E54" cite_class="article_self_cite">we </ENAMEX>assayed expression of <ENAMEX type="TERM" id="NYU_TERM_515" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21</ENAMEX>, Bax, and <ENAMEX type="TERM" id="NYU_TERM_46" string="HDAC1" frequency="8" lemma="HISTONE DEACETYLASE 1" lemma_frequency="8" term_pattern_type="chunk-based:['NOUN_OOV']">HDAC1 </ENAMEX>in these embryos by <ENAMEX type="TERM" id="NYU_TERM_569" string="real-time PCR" frequency="1" lemma="REAL-TIME PCR" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV']">real-time PCR</ENAMEX>. 
15180 The rationale for doing so is that <ENAMEX type="TERM" id="NYU_TERM_107" string="ING2 activation" frequency="1" lemma="ING2 ACTIVATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">ING2 activation </ENAMEX>leads to <ENAMEX type="TERM" id="NYU_TERM_616" string="up-regulation" frequency="1" lemma="UP-REGULATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">up-regulation </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_516" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21 </ENAMEX>and Bax in a number of <ENAMEX type="TERM" id="NYU_TERM_282" string="cancer cell lines" frequency="1" lemma="CANCER CELL LINE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN', 'AMBIG_PLURAL']">cancer cell lines </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_152" string="Nagashima" frequency="1" lemma="NAGASHIMA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Nagashima </ENAMEX>et al., 2001). 
15328 Additionally, <ENAMEX type="TERM" id="NYU_TERM_42" string="HDAC inhibitors" frequency="1" lemma="HDAC INHIBITOR" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'PLURAL']">HDAC inhibitors </ENAMEX>have been shown to induce expression of <ENAMEX type="TERM" id="NYU_TERM_517" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21 </ENAMEX>in many cell types and tumors, leading to cell cycle arrest (Zhu et al., 2004). 
15482 <ENAMEX type="TERM" id="NYU_TERM_120" string="Induction" frequency="1" lemma="INDUCTION" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN']">Induction </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_518" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21 </ENAMEX>was also observed in <ENAMEX type="TERM" id="NYU_TERM_58" string="Hdac1-deficient embryonic" frequency="2" lemma="HDAC1-DEFICIENT EMBRYONIC" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'TECH_ADJECTIVE']">Hdac1-deficient embryonic </ENAMEX>stem cells (<ENAMEX type="TERM" id="NYU_TERM_144" string="Lagger" frequency="2" lemma="LAGGER" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Lagger </ENAMEX>et al., 2002). 
15580 In <ENAMEX type="CITATION" id="NYU_RELATION_55" nyu_id="E55" cite_class="article_self_cite">this study</ENAMEX>, <ENAMEX type="CITATION" id="NYU_RELATION_56" nyu_id="E56" cite_class="article_self_cite">we </ENAMEX>observed a 2.3-fold increase in <ENAMEX type="TERM" id="NYU_TERM_524" string="p21 mRNA expression level" frequency="1" lemma="P21 MRNA EXPRESSION LEVEL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'TECH_ADJECTIVE', 'NOUN', 'NOUN']">p21 mRNA expression level </ENAMEX>at the early <ENAMEX type="TERM" id="NYU_TERM_269" string="blastocyst stage" frequency="7" lemma="BLASTOCYST STAGE" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst stage </ENAMEX>(96 <ENAMEX type="TERM" id="NYU_TERM_408" string="h post-hCG injection" frequency="1" lemma="H POST-HCG INJECTION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN', 'NOUN']">h post-hCG injection</ENAMEX>), while there was a corresponding 85% decrease in <ENAMEX type="TERM" id="NYU_TERM_51" string="HDAC1 mRNA level" frequency="1" lemma="HDAC1 MRNA LEVEL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'TECH_ADJECTIVE', 'NOUN']">HDAC1 mRNA level </ENAMEX>at the same <ENAMEX type="TERM" id="NYU_TERM_608" string="time point" frequency="1" lemma="TIME POINT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">time point </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_136" string="Ing2-depleted embryos" frequency="2" lemma="ING2-DEPLETED EMBRYO" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'PLURAL']">Ing2-depleted embryos </ENAMEX>(Fig. 4). 
15836 It is hypothesized that the <ENAMEX type="TERM" id="NYU_TERM_112" string="ING2-induced developmental delay" frequency="1" lemma="ING2-INDUCED DEVELOPMENTAL DELAY" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'TECH_ADJECTIVE', 'NOUN']">ING2-induced developmental delay </ENAMEX>could be due to <ENAMEX type="TERM" id="NYU_TERM_314" string="decreased expression" frequency="2" lemma="DECREASED EXPRESSION" lemma_frequency="2" term_pattern_type="chunk-based:['VERB', 'NOUN']">decreased expression </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_47" string="HDAC1" frequency="8" lemma="HISTONE DEACETYLASE 1" lemma_frequency="8" term_pattern_type="chunk-based:['NOUN_OOV']">HDAC1 </ENAMEX>and concomitant increased expression of <ENAMEX type="TERM" id="NYU_TERM_519" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21</ENAMEX>, and may not be associated with <ENAMEX type="TERM" id="NYU_TERM_251" string="apoptosis" frequency="2" lemma="APOPTOSI" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">apoptosis </ENAMEX>because there was no increase in the expression of the <ENAMEX type="TERM" id="NYU_TERM_564" string="pro-apoptotic Bax transcripts" frequency="1" lemma="PRO-APOPTOTIC BAX TRANSCRIPT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'PERSON_NAME', 'PLURAL']">pro-apoptotic Bax transcripts </ENAMEX>(Fig. 4). 
16125 Figure 4 <ENAMEX type="TERM" id="NYU_TERM_188" string="Real-time PCR analysis" frequency="3" lemma="REAL-TIME PCR ANALYSIS" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN_OOV', 'NOUN']">Real-time PCR analysis </ENAMEX>of expression of <ENAMEX type="TERM" id="NYU_TERM_134" string="Ing2-associated genes" frequency="1" lemma="ING2-ASSOCIATED GENE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'PLURAL']">Ing2-associated genes </ENAMEX>in early <ENAMEX type="TERM" id="NYU_TERM_273" string="blastocyst stage embryos" frequency="1" lemma="BLASTOCYST STAGE EMBRYO" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'PLURAL']">blastocyst stage embryos </ENAMEX>after <ENAMEX type="TERM" id="NYU_TERM_465" string="microinjection" frequency="3" lemma="MICROINJECTION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">microinjection </ENAMEX>with <ENAMEX type="TERM" id="NYU_TERM_85" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>specific <ENAMEX type="TERM" id="NYU_TERM_378" string="esiRNA" frequency="2" lemma="ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">esiRNA</ENAMEX>. 
16279 The control and <ENAMEX type="TERM" id="NYU_TERM_281" string="calibration sample" frequency="3" lemma="CALIBRATION SAMPLE" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">calibration sample </ENAMEX>was untreated embryos at the same <ENAMEX type="TERM" id="NYU_TERM_329" string="developmental stage" frequency="1" lemma="DEVELOPMENTAL STAGE" lemma_frequency="4" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental stage </ENAMEX>(early <ENAMEX type="TERM" id="NYU_TERM_261" string="blastocyst" frequency="3" lemma="BLASTOCYST" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">blastocyst</ENAMEX>). 
16388 Data are presented as the <ENAMEX type="TERM" id="NYU_TERM_460" string="mean" frequency="1" lemma="MEAN" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">mean </ENAMEX>of at least three <ENAMEX type="TERM" id="NYU_TERM_258" string="biological replicates" frequency="1" lemma="BIOLOGICAL REPLICATE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">biological replicates</ENAMEX>. 
16460 Bar graphs indicate mean standard deviation (SD); *P 0.05 vs. control. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="16537" END="16548"
16537 Discussion 
SECTION ID="" TYPE="doc_segment" TITLE="" START="16548" END="16798"
16548 In <ENAMEX type="CITATION" id="NYU_RELATION_57" nyu_id="E57" cite_class="article_self_cite">this study</ENAMEX>, <ENAMEX type="CITATION" id="NYU_RELATION_58" nyu_id="E58" cite_class="article_self_cite">we </ENAMEX>investigated the expression and <ENAMEX type="TERM" id="NYU_TERM_450" string="localization" frequency="3" lemma="LOCALIZATION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN']">localization </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_86" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>during mouse <ENAMEX type="TERM" id="NYU_TERM_543" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development</ENAMEX>. 
16661 <ENAMEX type="CITATION" id="NYU_RELATION_59" nyu_id="E59" cite_class="article_self_cite">We </ENAMEX>also demonstrated its <ENAMEX type="TERM" id="NYU_TERM_533" string="physiological function" frequency="1" lemma="PHYSIOLOGICAL FUNCTION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">physiological function </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_359" string="embryonic development" frequency="6" lemma="EMBRYONIC DEVELOPMENT" lemma_frequency="6" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">embryonic development </ENAMEX>and made <ENAMEX type="TERM" id="NYU_TERM_562" string="preliminary investigations" frequency="1" lemma="PRELIMINARY INVESTIGATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">preliminary investigations </ENAMEX>on its mechanism of action. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="16798" END="18381"
16798 <ENAMEX type="TERM" id="NYU_TERM_181" string="RT-PCR analysis" frequency="2" lemma="RT-PCR ANALYSIS" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">RT-PCR analysis </ENAMEX>revealed that there was a marked increase in <ENAMEX type="TERM" id="NYU_TERM_130" string="Ing2 expression" frequency="4" lemma="ING2 EXPRESSION" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">Ing2 expression </ENAMEX>from the 2-cell to 4-cell embryo stage. 
16915 This is consistent with the <ENAMEX type="TERM" id="NYU_TERM_418" string="immunostaining results" frequency="1" lemma="IMMUNOSTAINING RESULT" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">immunostaining results</ENAMEX>, which showed an increase in expression of <ENAMEX type="TERM" id="NYU_TERM_87" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>at the <ENAMEX type="TERM" id="NYU_TERM_568" string="protein level" frequency="2" lemma="PROTEIN LEVEL" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'NOUN']">protein level </ENAMEX>from the 2-cell embryo stage, together with <ENAMEX type="TERM" id="NYU_TERM_432" string="increasing localization" frequency="1" lemma="INCREASING LOCALIZATION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">increasing localization </ENAMEX>within the <ENAMEX type="TERM" id="NYU_TERM_508" string="nucleus" frequency="1" lemma="NUCLEUS" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">nucleus </ENAMEX>of 4-cell <ENAMEX type="TERM" id="NYU_TERM_276" string="blastomeres" frequency="1" lemma="BLASTOMERE" lemma_frequency="1" term_pattern_type="chunk-based:['PLURAL']">blastomeres</ENAMEX>. 
17145 In mouse, the first upsurge of <ENAMEX type="TERM" id="NYU_TERM_397" string="gene expression" frequency="3" lemma="GENE EXPRESSION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">gene expression </ENAMEX>occurs at the 2-cell embryo stage, and is known as <ENAMEX type="TERM" id="NYU_TERM_626" string="zygotic genome activation" frequency="1" lemma="ZYGOTIC GENOME ACTIVATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'NOUN']">zygotic genome activation </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_13">ZGA) (Flach et al., 1982</ENAMEX>; 
17296 <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_14">Latham et al., 1992</ENAMEX>; 
17317 <ENAMEX type="TERM" id="NYU_TERM_158" string="Nothias" frequency="1" lemma="NOTHIA" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Nothias </ENAMEX>et al., 1995). 
17340 From then onwards, the <ENAMEX type="TERM" id="NYU_TERM_351" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo </ENAMEX>will exploit its own <ENAMEX type="TERM" id="NYU_TERM_611" string="transcriptional" frequency="1" lemma="TRANSCRIPTIONAL" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">transcriptional </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_612" string="translational machinery" frequency="1" lemma="TRANSLATIONAL MACHINERY" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">translational machinery </ENAMEX>to carry out its <ENAMEX type="TERM" id="NYU_TERM_326" string="developmental program" frequency="1" lemma="DEVELOPMENTAL PROGRAM" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental program</ENAMEX>. 
17475 This enables <ENAMEX type="TERM" id="NYU_TERM_575" string="reprogramming" frequency="1" lemma="REPROGRAMMING" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">reprogramming </ENAMEX>of the newly formed <ENAMEX type="TERM" id="NYU_TERM_366" string="embryonic genome" frequency="1" lemma="EMBRYONIC GENOME" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">embryonic genome </ENAMEX>to a <ENAMEX type="TERM" id="NYU_TERM_609" string="totipotent state" frequency="1" lemma="TOTIPOTENT STATE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">totipotent state</ENAMEX>, which is subsequently lost at the <ENAMEX type="TERM" id="NYU_TERM_270" string="blastocyst stage" frequency="7" lemma="BLASTOCYST STAGE" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst stage </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_26" string="Duranthon" frequency="1" lemma="DURANTHON" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Duranthon </ENAMEX>et al., 2008; 
17638 <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_15">Calle et al., 2012</ENAMEX>). 
17659 <ENAMEX type="TERM" id="NYU_TERM_170" string="Previous research" frequency="1" lemma="PREVIOUS RESEARCH" lemma_frequency="1" term_pattern_type="chunk-based:['ADJECTIVE', 'NOUN']">Previous research </ENAMEX>suggested that genes activated from the transition of fertilized eggs to 4-cell embryos contribute mainly to the regulation of basic <ENAMEX type="TERM" id="NYU_TERM_283" string="cellular machinery" frequency="1" lemma="CELLULAR MACHINERY" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">cellular machinery</ENAMEX>, while genes activated from transition of 8-cell embryos to the <ENAMEX type="TERM" id="NYU_TERM_488" string="morula" frequency="5" lemma="MORULA" lemma_frequency="5" term_pattern_type="chunk-based:['NOUN_OOV']">morula </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_274" string="blastocyst stages" frequency="1" lemma="BLASTOCYST STAGE" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">blastocyst stages </ENAMEX>are mainly associated with dramatic biological and <ENAMEX type="TERM" id="NYU_TERM_483" string="morphological events" frequency="1" lemma="MORPHOLOGICAL EVENT" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">morphological events </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_56" string="Hamatani" frequency="2" lemma="HAMATANI" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Hamatani </ENAMEX>et al., 2004). 
18019 The <ENAMEX type="TERM" id="NYU_TERM_592" string="spatio-temporal expression pattern" frequency="1" lemma="SPATIO-TEMPORAL EXPRESSION PATTERN" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN', 'NOUN']">spatio-temporal expression pattern </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_88" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2</ENAMEX>, may give some cues on how it may contribute to mouse <ENAMEX type="TERM" id="NYU_TERM_544" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development</ENAMEX>. 
18149 <ENAMEX type="TERM" id="NYU_TERM_31" string="Further investigation" frequency="1" lemma="FURTHER INVESTIGATION" lemma_frequency="1" term_pattern_type="chunk-based:['ADJECTIVE', 'NOUN']">Further investigation </ENAMEX>showed that <ENAMEX type="TERM" id="NYU_TERM_338" string="down-regulation" frequency="2" lemma="DOWN-REGULATION" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN']">down-regulation </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_89" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>by <ENAMEX type="TERM" id="NYU_TERM_173" string="RNAi" frequency="1" lemma="RNAI" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">RNAi </ENAMEX>led to a decreased <ENAMEX type="TERM" id="NYU_TERM_265" string="blastocyst formation rate" frequency="1" lemma="BLASTOCYST FORMATION RATE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">blastocyst formation rate </ENAMEX>compared with the <ENAMEX type="TERM" id="NYU_TERM_501" string="negative control group" frequency="2" lemma="NEGATIVE CONTROL GROUP" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">negative control group</ENAMEX>, which means that <ENAMEX type="TERM" id="NYU_TERM_90" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>does play a crucial role in <ENAMEX type="TERM" id="NYU_TERM_545" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development</ENAMEX>. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="18381" END="20564"
18381 As a <ENAMEX type="TERM" id="NYU_TERM_406" string="growth inhibition factor" frequency="1" lemma="GROWTH INHIBITION FACTOR" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN', 'NOUN']">growth inhibition factor</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_91" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>has a PHD domain that enables its interaction with H3K4Me3 to regulate <ENAMEX type="TERM" id="NYU_TERM_401" string="gene repression" frequency="3" lemma="GENE REPRESSION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">gene repression </ENAMEX>(<ENAMEX type="TERM" id="NYU_TERM_34" string="Gozani" frequency="1" lemma="GOZANI" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Gozani </ENAMEX>et al., 2003; 
18526 Shi et al., 2006). 
18545 <ENAMEX type="TERM" id="NYU_TERM_92" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>is a stable component of the <ENAMEX type="TERM" id="NYU_TERM_204" string="Sin3 HDAC complex" frequency="4" lemma="SIN3 HDAC COMPLEX" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'NOUN']">Sin3 HDAC complex</ENAMEX>. 
18598 It has been shown that <ENAMEX type="TERM" id="NYU_TERM_93" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>negatively regulates cell proliferation, <ENAMEX type="TERM" id="NYU_TERM_290" string="chromatin remodeling" frequency="1" lemma="CHROMATIN REMODELING" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">chromatin remodeling</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_252" string="apoptosis" frequency="2" lemma="APOPTOSI" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">apoptosis </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_24" string="DNA repair" frequency="2" lemma="DNA REPAIR" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">DNA repair </ENAMEX>through <ENAMEX type="TERM" id="NYU_TERM_474" string="modulation" frequency="1" lemma="MODULATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">modulation </ENAMEX>of the <ENAMEX type="TERM" id="NYU_TERM_526" string="p53 acetylation pathway" frequency="1" lemma="P53 ACETYLATION PATHWAY" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'NOUN']">p53 acetylation pathway</ENAMEX>, which incidentally enhance its own <ENAMEX type="TERM" id="NYU_TERM_610" string="transcription" frequency="1" lemma="TRANSCRIPTION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">transcription </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_16">Wang et al., 2006</ENAMEX>; 
18834 <ENAMEX type="TERM" id="NYU_TERM_237" string="Unoki" frequency="2" lemma="UNOKI" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Unoki </ENAMEX>et al., 2008). 
18855 Additionally, <ENAMEX type="TERM" id="NYU_TERM_94" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>has also been implicated in <ENAMEX type="TERM" id="NYU_TERM_496" string="muscle differentiation" frequency="1" lemma="MUSCLE DIFFERENTIATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">muscle differentiation </ENAMEX>through regulation of <ENAMEX type="TERM" id="NYU_TERM_497" string="myogenin transcription" frequency="1" lemma="MYOGENIN TRANSCRIPTION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">myogenin transcription </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_17">Eapen et al., 2012</ENAMEX>). 
18992 The <ENAMEX type="TERM" id="NYU_TERM_613" string="tri-methylated histone mark" frequency="1" lemma="TRI-METHYLATED HISTONE MARK" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'TECH_ADJECTIVE', 'NOUN']">tri-methylated histone mark </ENAMEX>is found mainly in transcriptionally active regions (Bannister & <ENAMEX type="TERM" id="NYU_TERM_143" string="Kouzarides" frequency="1" lemma="KOUZARIDE" lemma_frequency="1" term_pattern_type="chunk-based:['PLURAL']">Kouzarides</ENAMEX>, 2004). 
19108 <ENAMEX type="TERM" id="NYU_TERM_95" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2</ENAMEX>, being a stable component of the <ENAMEX type="TERM" id="NYU_TERM_205" string="Sin3 HDAC complex" frequency="4" lemma="SIN3 HDAC COMPLEX" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'NOUN']">Sin3 HDAC complex</ENAMEX>, recruits and stabilizes the <ENAMEX type="TERM" id="NYU_TERM_206" string="Sin3 HDAC complex" frequency="4" lemma="SIN3 HDAC COMPLEX" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'NOUN']">Sin3 HDAC complex </ENAMEX>on <ENAMEX type="TERM" id="NYU_TERM_399" string="gene promoters" frequency="1" lemma="GENE PROMOTER" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'PLURAL']">gene promoters</ENAMEX>, leading to histone <ENAMEX type="TERM" id="NYU_TERM_311" string="deacetylation" frequency="1" lemma="DEACETYLATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">deacetylation </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_402" string="gene repression" frequency="3" lemma="GENE REPRESSION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN', 'NOUN']">gene repression </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_18">Doyon et al., 2006</ENAMEX>; 
19304 <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_19">Pena et al., 2006</ENAMEX>; 
19323 Shi et al., 2006). 
19342 <ENAMEX type="TERM" id="NYU_TERM_60" string="Histone deacetylase" frequency="1" lemma="HISTONE DEACETYLASE" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">Histone deacetylase </ENAMEX>(HDAC) inhibitors cause the <ENAMEX type="TERM" id="NYU_TERM_335" string="dissociation" frequency="1" lemma="DISSOCIATION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">dissociation </ENAMEX>of the PHD domain <ENAMEX type="TERM" id="NYU_TERM_304" string="containing ING2 subunit" frequency="1" lemma="CONTAINING ING2 SUBUNIT" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN_OOV', 'NOUN_OOV']">containing ING2 subunit </ENAMEX>from the <ENAMEX type="TERM" id="NYU_TERM_210" string="Sin3 deacetylase complex" frequency="1" lemma="SIN3 DEACETYLASE COMPLEX" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">Sin3 deacetylase complex</ENAMEX>. 
19480 The loss of <ENAMEX type="TERM" id="NYU_TERM_96" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>subsequently disrupts the <ENAMEX type="TERM" id="NYU_TERM_425" string="in vivo binding" frequency="1" lemma="IN VIVO BINDING" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">in vivo binding </ENAMEX>of the <ENAMEX type="TERM" id="NYU_TERM_209" string="Sin3 complex" frequency="2" lemma="SIN3 COMPLEX" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">Sin3 complex </ENAMEX>to the <ENAMEX type="TERM" id="NYU_TERM_525" string="p21 promoter" frequency="1" lemma="P21 PROMOTER" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">p21 promoter </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_20">Smith et al., 2010</ENAMEX>). 
19601 In <ENAMEX type="CITATION" id="NYU_RELATION_60" nyu_id="E60" cite_class="article_self_cite">this study</ENAMEX>, <ENAMEX type="CITATION" id="NYU_RELATION_61" nyu_id="E61" cite_class="article_self_cite">we </ENAMEX>found that <ENAMEX type="TERM" id="NYU_TERM_523" string="p21 expression" frequency="1" lemma="P21 EXPRESSION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN']">p21 expression </ENAMEX>was significantly increased in <ENAMEX type="TERM" id="NYU_TERM_97" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>knockdown embryos. 
19700 Additionally, there was dramatically <ENAMEX type="TERM" id="NYU_TERM_315" string="decreased expression" frequency="2" lemma="DECREASED EXPRESSION" lemma_frequency="2" term_pattern_type="chunk-based:['VERB', 'NOUN']">decreased expression </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_48" string="HDAC1" frequency="8" lemma="HISTONE DEACETYLASE 1" lemma_frequency="8" term_pattern_type="chunk-based:['NOUN_OOV']">HDAC1 </ENAMEX>in these <ENAMEX type="TERM" id="NYU_TERM_98" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>knockdown embryos. 
19800 <ENAMEX type="CITATION" id="NYU_RELATION_62" nyu_id="E62" cite_class="article_self_cite">These results </ENAMEX>thus suggest that <ENAMEX type="TERM" id="NYU_TERM_520" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21 </ENAMEX>as well as <ENAMEX type="TERM" id="NYU_TERM_49" string="HDAC1" frequency="8" lemma="HISTONE DEACETYLASE 1" lemma_frequency="8" term_pattern_type="chunk-based:['NOUN_OOV']">HDAC1 </ENAMEX>may contribute to the regulation of <ENAMEX type="TERM" id="NYU_TERM_558" string="preimplantation embryonic development" frequency="7" lemma="PREIMPLANTATION EMBRYONIC DEVELOPMENT" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">preimplantation embryonic development</ENAMEX>. 
19928 <ENAMEX type="TERM" id="NYU_TERM_171" string="Previous studies" frequency="1" lemma="PREVIOUS STUDY" lemma_frequency="1" term_pattern_type="chunk-based:['ADJECTIVE', 'AMBIG_PLURAL']">Previous studies </ENAMEX>show that <ENAMEX type="TERM" id="NYU_TERM_339" string="down-regulation" frequency="2" lemma="DOWN-REGULATION" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN']">down-regulation </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_50" string="HDAC1" frequency="8" lemma="HISTONE DEACETYLASE 1" lemma_frequency="8" term_pattern_type="chunk-based:['NOUN_OOV']">HDAC1 </ENAMEX>leads to hyperacetylation of <ENAMEX type="TERM" id="NYU_TERM_410" string="histone H4" frequency="1" lemma="HISTONE H4" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV']">histone H4</ENAMEX>, which in <ENAMEX type="TERM" id="NYU_TERM_615" string="turn results" frequency="1" lemma="TURN RESULT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'AMBIG_PLURAL']">turn results </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_322" string="developmental delay" frequency="2" lemma="DEVELOPMENTAL DELAY" lemma_frequency="2" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">developmental delay</ENAMEX>. 
20067 The underlying <ENAMEX type="TERM" id="NYU_TERM_479" string="molecular mechanism" frequency="1" lemma="MOLECULAR MECHANISM" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">molecular mechanism </ENAMEX>involves <ENAMEX type="TERM" id="NYU_TERM_428" string="increased expression" frequency="2" lemma="INCREASED EXPRESSION" lemma_frequency="2" term_pattern_type="chunk-based:['VERB', 'NOUN']">increased expression </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_521" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21</ENAMEX>, without any increase in expression of either the pro-apoptotic Bax or <ENAMEX type="TERM" id="NYU_TERM_8" string="Bcl2 transcripts" frequency="1" lemma="BCL2 TRANSCRIPT" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'PLURAL']">Bcl2 transcripts </ENAMEX>within the <ENAMEX type="TERM" id="NYU_TERM_52" string="HDAC1-depleted embryos" frequency="1" lemma="HDAC1-DEPLETED EMBRYO" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'PLURAL']">HDAC1-depleted embryos </ENAMEX><ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_21">(Ma & Schultz, 2008). Additionally</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_434" string="induction" frequency="1" lemma="INDUCTION" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN']">induction </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_522" string="p21" frequency="9" lemma="P21" lemma_frequency="9" term_pattern_type="chunk-based:['NOUN_OOV']">p21 </ENAMEX>was also observed in <ENAMEX type="TERM" id="NYU_TERM_59" string="Hdac1-deficient embryonic" frequency="2" lemma="HDAC1-DEFICIENT EMBRYONIC" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'TECH_ADJECTIVE']">Hdac1-deficient embryonic </ENAMEX>stem cells (<ENAMEX type="TERM" id="NYU_TERM_145" string="Lagger" frequency="2" lemma="LAGGER" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">Lagger </ENAMEX>et al., 2002). 
20395 In summary, <ENAMEX type="CITATION" id="NYU_RELATION_63" nyu_id="E63" cite_class="article_self_cite">this study </ENAMEX>has demonstrated that <ENAMEX type="TERM" id="NYU_TERM_99" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>plays important roles in mouse <ENAMEX type="TERM" id="NYU_TERM_546" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development </ENAMEX>which may be associated with complex <ENAMEX type="TERM" id="NYU_TERM_375" string="epigenetic mechanisms" frequency="1" lemma="EPIGENETIC MECHANISM" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">epigenetic mechanisms</ENAMEX>. 
SECTION ID="" TYPE="doc_segment" TITLE="" START="20564" END="21131"
20564 Nevertheless, it must be noted that although <ENAMEX type="CITATION" id="NYU_RELATION_64" nyu_id="E64" cite_class="article_self_cite">our </ENAMEX>results do show that <ENAMEX type="TERM" id="NYU_TERM_100" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>plays a crucial role in <ENAMEX type="TERM" id="NYU_TERM_547" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development</ENAMEX>, it is unlikely to be the unique <ENAMEX type="TERM" id="NYU_TERM_477" string="modulator" frequency="2" lemma="MODULATOR" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">modulator </ENAMEX>of this process. 
20751 As seen in Fig. 3
20768 C and Table 1, only a certain percentage of embryos are affected by <ENAMEX type="TERM" id="NYU_TERM_466" string="microinjection" frequency="3" lemma="MICROINJECTION" lemma_frequency="3" term_pattern_type="chunk-based:['NOUN_OOV']">microinjection </ENAMEX>of <ENAMEX type="TERM" id="NYU_TERM_114" string="ING2-specific esiRNA" frequency="2" lemma="ING2-SPECIFIC ESIRNA" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV']">ING2-specific esiRNA</ENAMEX>. 
20876 This could suggest the existence of multiple redundant signalling pathways in <ENAMEX type="TERM" id="NYU_TERM_548" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development</ENAMEX>. 
20983 Indeed, it has been hypothesized that this redundancy may provide a fail-safe protection to the <ENAMEX type="TERM" id="NYU_TERM_550" string="preimplantation development programme" frequency="1" lemma="PREIMPLANTATION DEVELOPMENT PROGRAMME" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'AMBIG_NOUN']">preimplantation development programme </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_22">Kaye, 1997</ENAMEX>). 
SECTION ID="" TYPE="doc_segment" TITLE="" START="21131" END="22562"
21131 As a basic <ENAMEX type="TERM" id="NYU_TERM_600" string="subunit" frequency="2" lemma="SUBUNIT" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN_OOV']">subunit </ENAMEX>of the <ENAMEX type="TERM" id="NYU_TERM_207" string="Sin3 HDAC complex" frequency="4" lemma="SIN3 HDAC COMPLEX" lemma_frequency="4" term_pattern_type="chunk-based:['NOUN_OOV', 'NOUN_OOV', 'NOUN']">Sin3 HDAC complex</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_108" string="ING2 displays" frequency="1" lemma="ING2 DISPLAY" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'AMBIG_PLURAL']">ING2 displays </ENAMEX>a high degree of <ENAMEX type="TERM" id="NYU_TERM_439" string="interspecies homology" frequency="1" lemma="INTERSPECIES HOMOLOGY" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN_OOV']">interspecies homology </ENAMEX>between human and mouse <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_23">(Guerillon et al., 2013). Hence</ENAMEX>, <ENAMEX type="CITATION" id="NYU_RELATION_65" nyu_id="E65" cite_class="article_self_cite">we </ENAMEX>hypothesize that <ENAMEX type="TERM" id="NYU_TERM_101" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>may also play a similar <ENAMEX type="TERM" id="NYU_TERM_446" string="key role" frequency="1" lemma="KEY ROLE" lemma_frequency="1" term_pattern_type="chunk-based:['AMBIG_NOUN', 'NOUN']">key role </ENAMEX>in human <ENAMEX type="TERM" id="NYU_TERM_559" string="preimplantation embryonic development" frequency="7" lemma="PREIMPLANTATION EMBRYONIC DEVELOPMENT" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'TECH_ADJECTIVE', 'NOUN']">preimplantation embryonic development</ENAMEX>. 
21392 In <ENAMEX type="TERM" id="NYU_TERM_295" string="clinical assisted reproduction" frequency="1" lemma="CLINICAL ASSISTED REPRODUCTION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'ADJECTIVE', 'NOUN']">clinical assisted reproduction</ENAMEX>, <ENAMEX type="TERM" id="NYU_TERM_509" string="obtaining high-quality embryos" frequency="1" lemma="OBTAINING HIGH-QUALITY EMBRYO" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN', 'PLURAL']">obtaining high-quality embryos </ENAMEX>is critical for improving the <ENAMEX type="TERM" id="NYU_TERM_538" string="pregnancy rate" frequency="1" lemma="PREGNANCY RATE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">pregnancy rate</ENAMEX>. 
21504 Additionally, extended culture and transfer of embryos at the <ENAMEX type="TERM" id="NYU_TERM_271" string="blastocyst stage" frequency="7" lemma="BLASTOCYST STAGE" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst stage </ENAMEX>for assisted <ENAMEX type="TERM" id="NYU_TERM_573" string="reproduction" frequency="1" lemma="REPRODUCTION" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">reproduction </ENAMEX>offers some <ENAMEX type="TERM" id="NYU_TERM_607" string="theoretical advantages" frequency="1" lemma="THEORETICAL ADVANTAGE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">theoretical advantages </ENAMEX>over the transfer of <ENAMEX type="TERM" id="NYU_TERM_294" string="cleavage-stage embryos" frequency="2" lemma="CLEAVAGE-STAGE EMBRYO" lemma_frequency="2" term_pattern_type="chunk-based:['NOUN', 'PLURAL']">cleavage-stage embryos</ENAMEX>. 
21689 For example, higher <ENAMEX type="TERM" id="NYU_TERM_420" string="implantation rates" frequency="1" lemma="IMPLANTATION RATE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV', 'AMBIG_PLURAL']">implantation rates</ENAMEX>, single <ENAMEX type="TERM" id="NYU_TERM_355" string="embryo transfer" frequency="1" lemma="EMBRYO TRANSFER" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN', 'NOUN']">embryo transfer </ENAMEX>and better <ENAMEX type="TERM" id="NYU_TERM_606" string="temporal synchronization" frequency="1" lemma="TEMPORAL SYNCHRONIZATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">temporal synchronization </ENAMEX>between <ENAMEX type="TERM" id="NYU_TERM_352" string="embryo" frequency="10" lemma="EMBRYO" lemma_frequency="10" term_pattern_type="chunk-based:['NOUN']">embryo </ENAMEX>and <ENAMEX type="TERM" id="NYU_TERM_374" string="endometrium" frequency="1" lemma="ENDOMETRIUM" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">endometrium </ENAMEX>can be achieved by transfer of embryos at the <ENAMEX type="TERM" id="NYU_TERM_272" string="blastocyst stage" frequency="7" lemma="BLASTOCYST STAGE" lemma_frequency="8" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">blastocyst stage </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_24">Jones et al., 1998</ENAMEX>; 
21903 <ENAMEX type="TERM" id="NYU_TERM_226" string="Tsirigotis" frequency="1" lemma="TSIRIGOTI" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Tsirigotis</ENAMEX>, 1998; <ENAMEX type="TERM" id="NYU_TERM_57" string="Hambiliki" frequency="1" lemma="HAMBILIKI" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Hambiliki </ENAMEX>et al., 2013). 
21946 However, the extended duration of <ENAMEX type="TERM" id="NYU_TERM_421" string="in vitro culture" frequency="1" lemma="IN VITRO CULTURE" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">in vitro culture </ENAMEX>involves high risk of reduction in the number of embryos available for transfer, because the <ENAMEX type="TERM" id="NYU_TERM_424" string="in vitro culture environment" frequency="1" lemma="IN VITRO CULTURE ENVIRONMENT" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN', 'NOUN']">in vitro culture environment </ENAMEX>may exert <ENAMEX type="TERM" id="NYU_TERM_319" string="detrimental effects" frequency="1" lemma="DETRIMENTAL EFFECT" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'AMBIG_PLURAL']">detrimental effects </ENAMEX>on <ENAMEX type="TERM" id="NYU_TERM_360" string="embryonic development" frequency="6" lemma="EMBRYONIC DEVELOPMENT" lemma_frequency="6" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">embryonic development </ENAMEX>(<ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_25">Jones et al., 1998</ENAMEX>; <ENAMEX type="CITATION" cite_class="article" id="NYU_ARTICLE_CITATION_26">Kawamura et al., 2012</ENAMEX>; 
22218 <ENAMEX type="TERM" id="NYU_TERM_15" string="Calzi" frequency="1" lemma="CALZI" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN_OOV']">Calzi </ENAMEX>et al., 2012). 
22239 Hence <ENAMEX type="TERM" id="NYU_TERM_577" string="rigorous characterization" frequency="1" lemma="RIGOROUS CHARACTERIZATION" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">rigorous characterization </ENAMEX>of the <ENAMEX type="TERM" id="NYU_TERM_571" string="regulatory mechanisms" frequency="1" lemma="REGULATORY MECHANISM" lemma_frequency="1" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'PLURAL']">regulatory mechanisms </ENAMEX>in <ENAMEX type="TERM" id="NYU_TERM_361" string="embryonic development" frequency="6" lemma="EMBRYONIC DEVELOPMENT" lemma_frequency="6" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">embryonic development </ENAMEX>is of great <ENAMEX type="TERM" id="NYU_TERM_590" string="significance" frequency="1" lemma="SIGNIFICANCE" lemma_frequency="1" term_pattern_type="chunk-based:['NOUN']">significance </ENAMEX>to clinical <ENAMEX type="TERM" id="NYU_TERM_254" string="assisted reproduction" frequency="1" lemma="ASSISTED REPRODUCTION" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'NOUN']">assisted reproduction</ENAMEX>. 
22385 <ENAMEX type="CITATION" id="NYU_RELATION_66" nyu_id="E66" cite_class="article_self_cite">This study </ENAMEX>sheds some light on the crucial role of <ENAMEX type="TERM" id="NYU_TERM_102" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>in mouse <ENAMEX type="TERM" id="NYU_TERM_549" string="preimplantation development" frequency="11" lemma="PREIMPLANTATION DEVELOPMENT" lemma_frequency="11" term_pattern_type="chunk-based:['TECH_ADJECTIVE', 'NOUN']">preimplantation development </ENAMEX>which gives an inkling on the function of <ENAMEX type="TERM" id="NYU_TERM_103" string="ING2" frequency="39" lemma="ING2" lemma_frequency="43" term_pattern_type="chunk-based:['NOUN_OOV']">ING2 </ENAMEX>in human in vitro cultured embryos. 
SECTION ID="" TYPE="doc_segment" TITLE="Competing interests" START="22562" END="22653"
22562 <ENAMEX type="TERM" id="NYU_TERM_17" string="Competing interests" frequency="1" lemma="COMPETING INTEREST" lemma_frequency="1" term_pattern_type="chunk-based:['VERB', 'AMBIG_PLURAL']">Competing interests </ENAMEX>The authors hereby declare that there are no conflicting interests. 
SECTION ID="" TYPE="doc_segment" TITLE="Acknowledgements" START="22653" END="22783"
22653 <ENAMEX type="TERM" id="NYU_TERM_3" string="Acknowledgements" frequency="1" lemma="ACKNOWLEDGEMENT" lemma_frequency="1" term_pattern_type="chunk-based:['PLURAL']">Acknowledgements </ENAMEX><ENAMEX type="CITATION" id="NYU_RELATION_67" nyu_id="E67" cite_class="article_self_cite">This work </ENAMEX>was financially supported by the <ENAMEX type="ORGANIZATION" id="NYU_ID_155" string="National Natural Science Foundation">National Natural Science Foundation </ENAMEX>of China (81100420, 81270701). 
